| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.706 | 0.03 | 0.865 | Antiinflammatory | 0.77 0.019 DB01024 0.865 0.008 DBMET00916 0.706 0.03 DBMET02607 0.77 0.019 DBMET02606 | DBMET00916 | |
| 0.687 | 0.022 | 0.943 | Transcription factor NF kappa B inhibitor | 0.82 0.011 DB01024 0.943 0.003 DBMET00916 0.687 0.022 DBMET02607 0.192 0.177 DBMET00918 0.2 0.169 DBMET00919 0.82 0.011 DBMET02606 | DBMET00916 | |
| 0.689 | 0.033 | 0.793 | Apoptosis agonist | 0.762 0.021 DB01024 0.793 0.017 DBMET00916 0.689 0.033 DBMET02607 0.762 0.021 DBMET02606 | DBMET00916 | |
| 0.66 | 0.007 | 0.718 | Immunosuppressant | 0.718 0.005 DB01024 0.714 0.005 DBMET00916 0.66 0.007 DBMET02607 0.265 0.137 DBMET00919 0.718 0.005 DBMET02606 | DBMET02606 | |
| 0.636 | 0.01 | 0.636 | Spasmolytic | 0.371 0.047 DB01024 0.442 0.032 DBMET00916 0.636 0.01 DBMET02607 0.385 0.043 DBMET00918 0.455 0.03 DBMET00919 0.173 0.142 DBMET00920 0.371 0.047 DBMET02606 | ||
| 0.615 | 0.009 | 0.782 | Lipoxygenase inhibitor | 0.782 0.004 DB01024 0.188 0.153 DBMET00916 0.615 0.009 DBMET02607 0.177 0.167 DBMET00918 0.782 0.004 DBMET02606 | DBMET02606 | |
| 0.586 | 0.011 | 0.844 | Histamine release inhibitor | 0.786 0.004 DB01024 0.844 0.003 DBMET00916 0.586 0.011 DBMET02607 0.381 0.085 DBMET00918 0.452 0.049 DBMET00919 0.22 0.18 DBMET00920 0.786 0.004 DBMET02606 | DBMET00916 | |
| 0.57 | 0.001 | 0.846 | Inosine monophosphate dehydrogenase inhibitor | 0.846 0.001 DB01024 0.378 0.002 DBMET00916 0.57 0.001 DBMET02607 0.846 0.001 DBMET02606 | DBMET02606 | |
| 0.561 | 0.001 | 0.766 | Inosine monophosphate dehydrogenase 1 inhibitor | 0.766 0.001 DB01024 0.494 0.001 DBMET00916 0.561 0.001 DBMET02607 0.766 0.001 DBMET02606 | DBMET02606 | |
| 0.561 | 0.014 | 0.762 | Antioxidant | 0.669 0.007 DB01024 0.762 0.005 DBMET00916 0.561 0.014 DBMET02607 0.176 0.136 DBMET00918 0.485 0.022 DBMET00920 0.669 0.007 DBMET02606 | DBMET00916 | |
| 0.509 | 0.004 | 0.637 | Mediator release inhibitor | 0.389 0.005 DB01024 0.637 0.003 DBMET00916 0.509 0.004 DBMET02607 0.143 0.032 DBMET00918 0.117 0.05 DBMET00919 0.389 0.005 DBMET02606 | DBMET00916 | |
| 0.492 | 0.005 | 0.563 | Lipid peroxidase inhibitor | 0.563 0.004 DB01024 0.552 0.004 DBMET00916 0.492 0.005 DBMET02607 0.159 0.062 DBMET00918 0.563 0.004 DBMET02606 | DBMET02606 | |
| 0.498 | 0.016 | 0.676 | Free radical scavenger | 0.589 0.009 DB01024 0.676 0.005 DBMET00916 0.498 0.016 DBMET02607 0.176 0.118 DBMET00918 0.614 0.008 DBMET00920 0.589 0.009 DBMET02606 | DBMET00916 | |
| 0.456 | 0.004 | 0.54 | Neurotrophic factor enhancer | 0.523 0.004 DB01024 0.54 0.003 DBMET00916 0.456 0.004 DBMET02607 0.236 0.047 DBMET00918 0.293 0.02 DBMET00919 0.153 0.133 DBMET00920 0.523 0.004 DBMET02606 | DBMET00916 | |
| 0.469 | 0.034 | 0.827 | Antithrombotic | 0.55 0.022 DB01024 0.827 0.004 DBMET00916 0.469 0.034 DBMET02607 0.423 0.044 DBMET00918 0.276 0.106 DBMET00919 0.55 0.022 DBMET02606 | DBMET00916 | |
| 0.411 | 0.004 | 0.411 | Antibacterial (Helicobacter pylori) | 0.304 0.007 DB01024 0.164 0.036 DBMET00916 0.411 0.004 DBMET02607 0.136 0.06 DBMET00918 0.162 0.037 DBMET00919 0.304 0.007 DBMET02606 | ||
| 0.385 | 0.001 | 0.836 | Inosine monophosphate dehydrogenase 2 inhibitor | 0.836 0.001 DB01024 0.197 0.002 DBMET00916 0.385 0.001 DBMET02607 0.836 0.001 DBMET02606 | DBMET02606 | |
| 0.453 | 0.095 | 0.584 | Alpha-glucosidase inhibitor | 0.373 0.126 DB01024 0.584 0.057 DBMET00916 0.453 0.095 DBMET02607 0.225 0.203 DBMET00919 0.373 0.126 DBMET02606 | DBMET00916 | |
| 0.4 | 0.045 | 0.486 | Caspase 3 stimulant | 0.486 0.022 DB01024 0.453 0.029 DBMET00916 0.4 0.045 DBMET02607 0.486 0.022 DBMET02606 | DBMET02606 | |
| 0.419 | 0.068 | 0.748 | Antibacterial | 0.567 0.025 DB01024 0.748 0.006 DBMET00916 0.419 0.068 DBMET02607 0.567 0.025 DBMET02606 | DBMET00916 | |
| 0.391 | 0.052 | 0.646 | Immunostimulant | 0.447 0.037 DB01024 0.646 0.012 DBMET00916 0.391 0.052 DBMET02607 0.245 0.098 DBMET00918 0.236 0.102 DBMET00919 0.19 0.126 DBMET00920 0.447 0.037 DBMET02606 | DBMET00916 | |
| 0.349 | 0.032 | 0.578 | Nitric oxide antagonist | 0.44 0.021 DB01024 0.578 0.011 DBMET00916 0.349 0.032 DBMET02607 0.44 0.021 DBMET02606 | DBMET00916 | |
| 0.348 | 0.045 | 0.348 | Hypoxia-inducible factor 1 alpha inhibitor | 0.303 0.064 DB01024 0.259 0.093 DBMET00916 0.348 0.045 DBMET02607 0.194 0.159 DBMET00918 0.234 0.115 DBMET00919 0.303 0.064 DBMET02606 | ||
| 0.348 | 0.057 | 0.557 | Apoptosis antagonist | 0.457 0.026 DB01024 0.557 0.014 DBMET00916 0.348 0.057 DBMET02607 0.457 0.026 DBMET02606 | DBMET00916 | |
| 0.306 | 0.029 | 0.347 | Gastrin inhibitor | 0.316 0.023 DB01024 0.243 0.088 DBMET00916 0.306 0.029 DBMET02607 0.347 0.011 DBMET00918 0.33 0.017 DBMET00919 0.204 0.143 DBMET00920 0.316 0.023 DBMET02606 | DBMET00918 | |
| 0.318 | 0.047 | 0.649 | Hypoglycemic | 0.456 0.02 DB01024 0.649 0.006 DBMET00916 0.318 0.047 DBMET02607 0.456 0.02 DBMET02606 | DBMET00916 | |
| 0.284 | 0.016 | 0.434 | Phospholipase A2 inhibitor | 0.434 0.004 DB01024 0.378 0.005 DBMET00916 0.284 0.016 DBMET02607 0.152 0.072 DBMET00918 0.434 0.004 DBMET02606 | DBMET02606 | |
| 0.306 | 0.046 | 0.465 | Vasodilator | 0.344 0.035 DB01024 0.465 0.015 DBMET00916 0.306 0.046 DBMET02607 0.155 0.15 DBMET00919 0.344 0.035 DBMET02606 | DBMET00916 | |
| 0.263 | 0.004 | 0.328 | Papain-like protease (SARS coronavirus) inhibitor | 0.328 0.003 DB01024 0.234 0.006 DBMET00916 0.263 0.004 DBMET02607 0.328 0.003 DBMET02606 | DBMET02606 | |
| 0.303 | 0.048 | 0.492 | Hypolipemic | 0.407 0.024 DB01024 0.492 0.013 DBMET00916 0.303 0.048 DBMET02607 0.19 0.102 DBMET00918 0.407 0.024 DBMET02606 | DBMET00916 | |
| 0.262 | 0.014 | 0.368 | 5-Lipoxygenase inhibitor | 0.368 0.006 DB01024 0.088 0.073 DBMET00916 0.262 0.014 DBMET02607 0.368 0.006 DBMET02606 | DBMET02606 | |
| 0.271 | 0.024 | 0.453 | Insulin sensitizer | 0.453 0.004 DB01024 0.357 0.009 DBMET00916 0.271 0.024 DBMET02607 0.166 0.112 DBMET00918 0.156 0.125 DBMET00919 0.453 0.004 DBMET02606 | DBMET02606 | |
| 0.28 | 0.036 | 0.506 | Hepatoprotectant | 0.338 0.021 DB01024 0.506 0.007 DBMET00916 0.28 0.036 DBMET02607 0.138 0.123 DBMET00918 0.338 0.021 DBMET02606 | DBMET00916 | |
| 0.342 | 0.104 | 0.38 | 15-Lipoxygenase inhibitor | 0.38 0.083 DB01024 0.342 0.104 DBMET02607 0.242 0.171 DBMET00918 0.38 0.083 DBMET02606 | DBMET02606 | |
| 0.242 | 0.018 | 0.342 | Topoisomerase I inhibitor | 0.292 0.012 DB01024 0.342 0.008 DBMET00916 0.242 0.018 DBMET02607 0.088 0.081 DBMET00919 0.292 0.012 DBMET02606 | DBMET00916 | |
| 0.261 | 0.038 | 0.261 | P-glycoprotein inhibitor | 0.228 0.05 DB01024 0.204 0.061 DBMET00916 0.261 0.038 DBMET02607 0.151 0.116 DBMET00918 0.218 0.054 DBMET00919 0.228 0.05 DBMET02606 | ||
| 0.229 | 0.021 | 0.27 | DNA polymerase I inhibitor | 0.27 0.014 DB01024 0.243 0.018 DBMET00916 0.229 0.021 DBMET02607 0.27 0.014 DBMET02606 | DBMET02606 | |
| 0.208 | 0.012 | 0.227 | Antineoplastic alkaloid | 0.227 0.007 DB01024 0.168 0.023 DBMET00916 0.208 0.012 DBMET02607 0.084 0.06 DBMET00918 0.227 0.007 DBMET02606 | DBMET02606 | |
| 0.214 | 0.03 | 0.719 | Monophenol monooxygenase inhibitor | 0.525 0.007 DB01024 0.719 0.004 DBMET00916 0.214 0.03 DBMET02607 0.525 0.007 DBMET02606 | DBMET00916 | |
| 0.232 | 0.051 | 0.482 | Non-steroidal antiinflammatory agent | 0.331 0.022 DB01024 0.482 0.007 DBMET00916 0.232 0.051 DBMET02607 0.222 0.056 DBMET00918 0.167 0.098 DBMET00919 0.331 0.022 DBMET02606 | DBMET00916 | |
| 0.215 | 0.039 | 0.78 | Amylase inhibitor | 0.523 0.005 DB01024 0.78 0.002 DBMET00916 0.215 0.039 DBMET02607 0.139 0.069 DBMET00918 0.146 0.066 DBMET00919 0.123 0.079 DBMET00920 0.523 0.005 DBMET02606 | DBMET00916 | |
| 0.253 | 0.079 | 0.31 | DNA damaging | 0.297 0.058 DB01024 0.31 0.053 DBMET00916 0.253 0.079 DBMET02607 0.24 0.086 DBMET00918 0.166 0.149 DBMET00919 0.297 0.058 DBMET02606 | DBMET00916 | |
| 0.204 | 0.045 | 0.339 | Protein-tyrosine phosphatase inhibitor | 0.339 0.013 DB01024 0.268 0.026 DBMET00916 0.204 0.045 DBMET02607 0.339 0.013 DBMET02606 | DBMET02606 | |
| 0.174 | 0.017 | 0.191 | Estrogen antagonist | 0.191 0.014 DB01024 0.127 0.043 DBMET00916 0.174 0.017 DBMET02607 0.138 0.03 DBMET00919 0.191 0.014 DBMET02606 | DBMET02606 | |
| 0.184 | 0.034 | 0.316 | Protein-tyrosine phosphatase 1B inhibitor | 0.316 0.009 DB01024 0.253 0.016 DBMET00916 0.184 0.034 DBMET02607 0.316 0.009 DBMET02606 | DBMET02606 | |
| 0.255 | 0.106 | 0.406 | 12-Lipoxygenase inhibitor | 0.406 0.038 DB01024 0.255 0.106 DBMET02607 0.406 0.038 DBMET02606 | DBMET02606 | |
| 0.154 | 0.009 | 0.173 | Lipase inhibitor | 0.173 0.008 DB01024 0.126 0.015 DBMET00916 0.154 0.009 DBMET02607 0.173 0.008 DBMET02606 | DBMET02606 | |
| 0.19 | 0.047 | 0.231 | Interleukin 6 antagonist | 0.206 0.037 DB01024 0.231 0.028 DBMET00916 0.19 0.047 DBMET02607 0.129 0.128 DBMET00919 0.206 0.037 DBMET02606 | DBMET00916 | |
| 0.156 | 0.014 | 0.171 | Estrogen receptor beta antagonist | 0.171 0.012 DB01024 0.098 0.069 DBMET00916 0.156 0.014 DBMET02607 0.118 0.034 DBMET00919 0.171 0.012 DBMET02606 | DBMET02606 | |
| 0.173 | 0.033 | 0.193 | Farnesoid X receptor antagonist | 0.193 0.024 DB01024 0.128 0.086 DBMET00916 0.173 0.033 DBMET02607 0.139 0.067 DBMET00918 0.168 0.036 DBMET00919 0.193 0.024 DBMET02606 | DBMET02606 | |
| 0.15 | 0.012 | 0.2 | Estrogen receptor alpha antagonist | 0.2 0.008 DB01024 0.15 0.012 DBMET02607 0.094 0.031 DBMET00919 0.2 0.008 DBMET02606 | DBMET02606 | |
| 0.184 | 0.049 | 0.228 | Arachidonic acid antagonist | 0.228 0.013 DB01024 0.152 0.086 DBMET00916 0.184 0.049 DBMET02607 0.195 0.038 DBMET00918 0.2 0.033 DBMET00919 0.178 0.056 DBMET00920 0.228 0.013 DBMET02606 | DBMET02606 | |
| 0.143 | 0.009 | 0.157 | ATPase (Vacuolar H+) inhibitor | 0.152 0.007 DB01024 0.157 0.006 DBMET00916 0.143 0.009 DBMET02607 0.099 0.041 DBMET00918 0.089 0.058 DBMET00919 0.152 0.007 DBMET02606 | DBMET00916 | |
| 0.181 | 0.051 | 0.519 | Melanin inhibitor | 0.388 0.013 DB01024 0.519 0.006 DBMET00916 0.181 0.051 DBMET02607 0.128 0.118 DBMET00919 0.388 0.013 DBMET02606 | DBMET00916 | |
| 0.159 | 0.03 | 0.191 | Vanilloid 1 agonist | 0.191 0.014 DB01024 0.162 0.028 DBMET00916 0.159 0.03 DBMET02607 0.15 0.038 DBMET00918 0.136 0.055 DBMET00919 0.121 0.086 DBMET00920 0.191 0.014 DBMET02606 | DBMET02606 | |
| 0.158 | 0.029 | 0.319 | Antineoplastic antibiotic | 0.237 0.016 DB01024 0.319 0.009 DBMET00916 0.158 0.029 DBMET02607 0.237 0.016 DBMET02606 | DBMET00916 | |
| 0.249 | 0.123 | 0.36 | Angiogenesis inhibitor | 0.279 0.104 DB01024 0.36 0.067 DBMET00916 0.249 0.123 DBMET02607 0.279 0.104 DBMET02606 | DBMET00916 | |
| 0.171 | 0.046 | 0.237 | Bone formation stimulant | 0.237 0.027 DB01024 0.177 0.043 DBMET00916 0.171 0.046 DBMET02607 0.175 0.044 DBMET00918 0.129 0.078 DBMET00919 0.237 0.027 DBMET02606 | DBMET02606 | |
| 0.166 | 0.043 | 0.292 | Topoisomerase II inhibitor | 0.226 0.028 DB01024 0.292 0.019 DBMET00916 0.166 0.043 DBMET02607 0.094 0.093 DBMET00918 0.226 0.028 DBMET02606 | DBMET00916 | |
| 0.13 | 0.008 | 0.16 | Ca(v)3.1 blocker | 0.16 0.005 DB01024 0.077 0.071 DBMET00916 0.13 0.008 DBMET02607 0.16 0.005 DBMET02606 | DBMET02606 | |
| 0.195 | 0.074 | 0.419 | Platelet adhesion inhibitor | 0.29 0.037 DB01024 0.419 0.01 DBMET00916 0.195 0.074 DBMET02607 0.147 0.11 DBMET00918 0.29 0.037 DBMET02606 | DBMET00916 | |
| 0.128 | 0.01 | 0.26 | Glycine receptor agonist | 0.225 0.004 DB01024 0.145 0.008 DBMET00916 0.128 0.01 DBMET02607 0.26 0.003 DBMET00918 0.169 0.005 DBMET00919 0.127 0.011 DBMET00920 0.225 0.004 DBMET02606 | DBMET00918 | |
| 0.138 | 0.029 | 0.145 | Breast cancer-resistant protein inhibitor | 0.145 0.025 DB01024 0.138 0.029 DBMET02607 0.145 0.025 DBMET02606 | DBMET02606 | |
| 0.242 | 0.137 | 0.348 | Sodium/bile acid cotransporter inhibitor | 0.348 0.041 DB01024 0.24 0.139 DBMET00916 0.242 0.137 DBMET02607 0.285 0.093 DBMET00918 0.329 0.055 DBMET00919 0.348 0.041 DBMET02606 | DBMET02606 | |
| 0.152 | 0.047 | 0.4 | Cyclooxygenase 3 inhibitor | 0.168 0.035 DB01024 0.4 0.004 DBMET00916 0.152 0.047 DBMET02607 0.151 0.047 DBMET00918 0.144 0.054 DBMET00919 0.136 0.061 DBMET00920 0.168 0.035 DBMET02606 | DBMET00916 | |
| 0.211 | 0.107 | 0.425 | DNA synthesis inhibitor | 0.31 0.04 DB01024 0.425 0.019 DBMET00916 0.211 0.107 DBMET02607 0.296 0.045 DBMET00918 0.299 0.044 DBMET00919 0.291 0.047 DBMET00920 0.31 0.04 DBMET02606 | DBMET00916 | |
| 0.201 | 0.1 | 0.53 | Platelet antagonist | 0.297 0.054 DB01024 0.383 0.031 DBMET00916 0.201 0.1 DBMET02607 0.53 0.011 DBMET00918 0.297 0.054 DBMET02606 | DBMET00918 | |
| 0.126 | 0.028 | 0.208 | Topoisomerase II alpha inhibitor | 0.174 0.019 DB01024 0.208 0.014 DBMET00916 0.126 0.028 DBMET02607 0.174 0.019 DBMET02606 | DBMET00916 | |
| 0.102 | 0.005 | 0.138 | Glucose-6-phosphate translocase inhibitor | 0.12 0.004 DB01024 0.138 0.004 DBMET00916 0.102 0.005 DBMET02607 0.12 0.004 DBMET02606 | DBMET00916 | |
| 0.13 | 0.036 | 0.175 | Electron transport complex I inhibitor | 0.175 0.012 DB01024 0.119 0.049 DBMET00916 0.13 0.036 DBMET02607 0.175 0.012 DBMET02606 | DBMET02606 | |
| 0.238 | 0.146 | 0.481 | Vasodilator, coronary | 0.32 0.073 DBMET00916 0.238 0.146 DBMET02607 0.481 0.018 DBMET00918 0.446 0.024 DBMET00919 0.287 0.098 DBMET00920 | DBMET00918 | |
| 0.09 | 0.004 | 0.13 | Pregnane X receptor antagonist | 0.13 0.002 DB01024 0.057 0.039 DBMET00916 0.09 0.004 DBMET02607 0.054 0.048 DBMET00918 0.06 0.03 DBMET00919 0.061 0.029 DBMET00920 0.13 0.002 DBMET02606 | DBMET02606 | |
| 0.109 | 0.025 | 0.13 | Vanilloid agonist | 0.13 0.015 DB01024 0.098 0.035 DBMET00916 0.109 0.025 DBMET02607 0.13 0.015 DBMET02606 | DBMET02606 | |
| 0.193 | 0.115 | 0.361 | Tumour necrosis factor alpha release inhibitor | 0.179 0.127 DB01024 0.361 0.035 DBMET00916 0.193 0.115 DBMET02607 0.179 0.127 DBMET02606 | DBMET00916 | |
| 0.107 | 0.035 | 0.17 | Bile acid receptor antagonist | 0.17 0.005 DB01024 0.107 0.036 DBMET00916 0.107 0.035 DBMET02607 0.115 0.025 DBMET00918 0.103 0.043 DBMET00919 0.1 0.049 DBMET00920 0.17 0.005 DBMET02606 | DBMET02606 | |
| 0.095 | 0.024 | 0.126 | Phosphodiesterase VI inhibitor | 0.075 0.051 DB01024 0.08 0.041 DBMET00916 0.095 0.024 DBMET02607 0.126 0.011 DBMET00919 0.075 0.051 DBMET02606 | DBMET00919 | |
| 0.075 | 0.005 | 0.092 | DNA gyrase subunit A inhibitor | 0.092 0.004 DB01024 0.067 0.008 DBMET00916 0.075 0.005 DBMET02607 0.092 0.004 DBMET02606 | DBMET02606 | |
| 0.128 | 0.059 | 0.268 | Cholesterol synthesis inhibitor | 0.268 0.015 DB01024 0.18 0.032 DBMET00916 0.128 0.059 DBMET02607 0.14 0.05 DBMET00918 0.127 0.059 DBMET00919 0.268 0.015 DBMET02606 | DBMET02606 | |
| 0.265 | 0.197 | 0.74 | Cyclophilin D inhibitor | 0.453 0.066 DB01024 0.74 0.01 DBMET00916 0.265 0.197 DBMET02607 0.639 0.021 DBMET00918 0.366 0.111 DBMET00920 0.453 0.066 DBMET02606 | DBMET00916 | |
| 0.15 | 0.085 | 0.456 | Sigma receptor agonist | 0.15 0.085 DBMET02607 0.276 0.043 DBMET00918 0.456 0.014 DBMET00919 | DBMET00919 | |
| 0.133 | 0.068 | 0.23 | Cyclooxygenase 1 inhibitor | 0.23 0.025 DB01024 0.154 0.054 DBMET00916 0.133 0.068 DBMET02607 0.23 0.025 DBMET02606 | DBMET02606 | |
| 0.103 | 0.041 | 0.156 | Ornithine decarboxylase inhibitor | 0.156 0.009 DB01024 0.103 0.041 DBMET00916 0.103 0.041 DBMET02607 0.091 0.054 DBMET00918 0.079 0.069 DBMET00919 0.156 0.009 DBMET02606 | DBMET02606 | |
| 0.121 | 0.059 | 0.235 | Microtubule formation inhibitor | 0.194 0.021 DB01024 0.235 0.013 DBMET00916 0.121 0.059 DBMET02607 0.134 0.048 DBMET00918 0.119 0.061 DBMET00919 0.103 0.086 DBMET00920 0.194 0.021 DBMET02606 | DBMET00916 | |
| 0.13 | 0.069 | 0.13 | MAO inhibitor | 0.122 0.073 DB01024 0.13 0.069 DBMET02607 0.122 0.073 DBMET02606 | ||
| 0.189 | 0.13 | 0.41 | Cardiotonic | 0.189 0.13 DBMET02607 0.176 0.144 DBMET00918 0.175 0.146 DBMET00919 0.41 0.027 DBMET00920 | DBMET00920 | |
| 0.123 | 0.064 | 0.183 | Beta amyloid protein antagonist | 0.177 0.025 DB01024 0.183 0.023 DBMET00916 0.123 0.064 DBMET02607 0.177 0.025 DBMET02606 | DBMET00916 | |
| 0.133 | 0.076 | 0.149 | Neurotrophic factor | 0.149 0.06 DB01024 0.133 0.076 DBMET00916 0.133 0.076 DBMET02607 0.149 0.06 DBMET02606 | DBMET02606 | |
| 0.059 | 0.003 | 0.059 | Potassium channel (Inward rectifier) 1 blocker | 0.058 0.004 DB01024 0.04 0.006 DBMET00916 0.059 0.003 DBMET02607 0.037 0.008 DBMET00919 0.058 0.004 DBMET02606 | ||
| 0.089 | 0.035 | 0.158 | CDC25A inhibitor | 0.158 0.011 DB01024 0.089 0.034 DBMET00916 0.089 0.035 DBMET02607 0.158 0.011 DBMET02606 | DBMET02606 | |
| 0.209 | 0.157 | 0.405 | Cholesterol antagonist | 0.287 0.1 DB01024 0.405 0.048 DBMET00916 0.209 0.157 DBMET02607 0.384 0.053 DBMET00918 0.402 0.049 DBMET00919 0.26 0.118 DBMET00920 0.287 0.1 DBMET02606 | DBMET00916 | |
| 0.082 | 0.031 | 0.235 | Peroxisome proliferator-activated receptor gamma antagonist | 0.235 0.004 DB01024 0.082 0.031 DBMET00916 0.082 0.031 DBMET02607 0.071 0.052 DBMET00918 0.235 0.004 DBMET02606 | DBMET02606 | |
| 0.192 | 0.15 | 0.482 | Tyrosine 3 hydroxylase inhibitor | 0.244 0.075 DB01024 0.192 0.15 DBMET02607 0.482 0.004 DBMET00918 0.384 0.01 DBMET00919 0.32 0.025 DBMET00920 0.244 0.075 DBMET02606 | DBMET00918 | |
| 0.103 | 0.062 | 0.126 | MAO A inhibitor | 0.126 0.049 DB01024 0.103 0.062 DBMET02607 0.126 0.049 DBMET02606 | DBMET02606 | |
| 0.085 | 0.046 | 0.144 | Na+ K+ transporting ATPase inhibitor | 0.12 0.016 DB01024 0.144 0.007 DBMET00916 0.085 0.046 DBMET02607 0.093 0.038 DBMET00918 0.086 0.044 DBMET00919 0.096 0.035 DBMET00920 0.12 0.016 DBMET02606 | DBMET00916 | |
| 0.102 | 0.066 | 0.533 | Expectorant | 0.261 0.011 DB01024 0.533 0.003 DBMET00916 0.102 0.066 DBMET02607 0.19 0.023 DBMET00918 0.105 0.063 DBMET00919 0.261 0.011 DBMET02606 | DBMET00916 | |
| 0.121 | 0.085 | 0.123 | Interleukin 4 antagonist | 0.108 0.104 DB01024 0.123 0.08 DBMET00916 0.121 0.085 DBMET02607 0.108 0.104 DBMET02606 | DBMET00916 | |
| 0.102 | 0.067 | 0.395 | AMP-activated protein kinase stimulant | 0.185 0.014 DB01024 0.395 0.004 DBMET00916 0.102 0.067 DBMET02607 0.129 0.042 DBMET00918 0.145 0.031 DBMET00919 0.185 0.014 DBMET02606 | DBMET00916 | |
| 0.074 | 0.041 | 0.128 | Leukotriene synthesis inhibitor | 0.128 0.014 DB01024 0.074 0.041 DBMET02607 0.128 0.014 DBMET02606 | DBMET02606 | |
| 0.101 | 0.072 | 0.141 | DNA intercalator | 0.094 0.08 DB01024 0.141 0.047 DBMET00916 0.101 0.072 DBMET02607 0.094 0.08 DBMET02606 | DBMET00916 | |
| 0.174 | 0.145 | 0.312 | RNA-directed DNA polymerase inhibitor | 0.211 0.085 DB01024 0.174 0.145 DBMET02607 0.214 0.081 DBMET00918 0.241 0.055 DBMET00919 0.312 0.029 DBMET00920 0.211 0.085 DBMET02606 | DBMET00920 | |
| 0.045 | 0.016 | 0.082 | Squalene synthetase inhibitor | 0.07 0.009 DB01024 0.082 0.008 DBMET00916 0.045 0.016 DBMET02607 0.07 0.009 DBMET02606 | DBMET00916 | |
| 0.102 | 0.075 | 0.21 | Mucolytic | 0.209 0.011 DB01024 0.18 0.019 DBMET00916 0.102 0.075 DBMET02607 0.21 0.011 DBMET00918 0.136 0.042 DBMET00919 0.095 0.085 DBMET00920 0.209 0.011 DBMET02606 | DBMET00918 | |
| 0.073 | 0.047 | 0.143 | Peroxisome proliferator-activated receptor gamma agonist | 0.143 0.014 DB01024 0.093 0.032 DBMET00916 0.073 0.047 DBMET02607 0.105 0.025 DBMET00918 0.143 0.014 DBMET02606 | DBMET02606 | |
| 0.132 | 0.107 | 0.333 | Interferon gamma antagonist | 0.22 0.035 DB01024 0.333 0.016 DBMET00916 0.132 0.107 DBMET02607 0.149 0.079 DBMET00918 0.15 0.078 DBMET00919 0.129 0.112 DBMET00920 0.22 0.035 DBMET02606 | DBMET00916 | |
| 0.195 | 0.17 | 0.409 | Immunomodulator | 0.21 0.152 DB01024 0.409 0.041 DBMET00916 0.195 0.17 DBMET02607 0.291 0.087 DBMET00918 0.271 0.099 DBMET00919 0.21 0.152 DBMET02606 | DBMET00916 | |
| 0.121 | 0.098 | 0.378 | Cell wall synthesis inhibitor | 0.224 0.022 DB01024 0.378 0.007 DBMET00916 0.121 0.098 DBMET02607 0.195 0.032 DBMET00918 0.198 0.031 DBMET00919 0.161 0.055 DBMET00920 0.224 0.022 DBMET02606 | DBMET00916 | |
| 0.154 | 0.131 | 0.158 | Potassium channel blocker | 0.154 0.131 DBMET02607 0.158 0.127 DBMET00919 | DBMET00919 | |
| 0.158 | 0.136 | 0.286 | Antiamyloidogenic | 0.241 0.075 DB01024 0.286 0.056 DBMET00916 0.158 0.136 DBMET02607 0.169 0.124 DBMET00918 0.16 0.134 DBMET00919 0.241 0.075 DBMET02606 | DBMET00916 | |
| 0.099 | 0.079 | 0.351 | Chelator | 0.113 0.061 DB01024 0.099 0.079 DBMET02607 0.351 0.008 DBMET00918 0.127 0.047 DBMET00919 0.113 0.061 DBMET02606 | DBMET00918 | |
| 0.043 | 0.03 | 0.061 | Leukocyte elastase inhibitor | 0.061 0.018 DB01024 0.043 0.03 DBMET02607 0.06 0.018 DBMET00918 0.061 0.018 DBMET02606 | DBMET02606 | |
| 0.115 | 0.105 | 0.178 | Cyclooxygenase inhibitor | 0.178 0.052 DB01024 0.126 0.092 DBMET00916 0.115 0.105 DBMET02607 0.178 0.052 DBMET02606 | DBMET02606 | |
| 0.13 | 0.12 | 0.18 | Dual specificity phosphatase inhibitor | 0.18 0.067 DB01024 0.13 0.12 DBMET02607 0.165 0.079 DBMET00918 0.159 0.085 DBMET00919 0.18 0.067 DBMET02606 | DBMET02606 | |
| 0.06 | 0.053 | 0.103 | Neuraminidase (influenza) inhibitor | 0.078 0.027 DB01024 0.103 0.015 DBMET00916 0.06 0.053 DBMET02607 0.078 0.027 DBMET02606 | DBMET00916 | |
| 0.058 | 0.052 | 0.071 | Nitric oxide donor | 0.071 0.031 DBMET00916 0.058 0.052 DBMET02607 | DBMET00916 | |
| 0.12 | 0.114 | 0.395 | Hemostatic | 0.151 0.066 DB01024 0.395 0.008 DBMET00916 0.12 0.114 DBMET02607 0.141 0.08 DBMET00918 0.127 0.1 DBMET00919 0.151 0.066 DBMET02606 | DBMET00916 | |
| 0.054 | 0.052 | 0.099 | Neuraminidase inhibitor | 0.083 0.023 DB01024 0.099 0.016 DBMET00916 0.054 0.052 DBMET02607 0.083 0.023 DBMET02606 | DBMET00916 | |
| 0.085 | 0.084 | 0.243 | Interleukin 12 antagonist | 0.086 0.081 DBMET00916 0.085 0.084 DBMET02607 0.181 0.007 DBMET00918 0.243 0.005 DBMET00919 0.126 0.024 DBMET00920 | DBMET00919 | |
| 0.077 | 0.077 | 0.086 | 3C-Like protease (SARS coronavirus) inhibitor | 0.086 0.053 DB01024 0.086 0.053 DBMET02606 | DBMET02606 | |
| 0.133 | 0.136 | 0.342 | ATPase inhibitor | 0.197 0.04 DB01024 0.342 0.004 DBMET00916 0.166 0.076 DBMET00918 0.185 0.052 DBMET00919 0.197 0.04 DBMET02606 | DBMET00916 | |
| 0.047 | 0.051 | 0.059 | Vanilloid 2 antagonist | 0.059 0.024 DB01024 0.059 0.024 DBMET02606 | DBMET02606 | |
| 0.03 | 0.035 | 0.045 | HMG CoA reductase inhibitor | 0.042 0.012 DB01024 0.045 0.01 DBMET00916 0.042 0.012 DBMET02606 | DBMET00916 | |
| 0.037 | 0.046 | 0.056 | Estrogen agonist | 0.056 0.032 DB01024 0.055 0.032 DBMET00916 0.056 0.032 DBMET02606 | DBMET02606 | |
| 0.044 | 0.055 | 0.05 | Elastase inhibitor | 0.05 0.041 DB01024 0.05 0.041 DBMET02606 | DBMET02606 | |
| 0.095 | 0.107 | 0.168 | Tubulin antagonist | 0.168 0.05 DB01024 0.168 0.05 DBMET02606 | DBMET02606 | |
| 0.073 | 0.085 | 0.222 | Thioredoxin reductase inhibitor | 0.079 0.065 DB01024 0.222 0.004 DBMET00920 0.079 0.065 DBMET02606 | DBMET00920 | |
| 0.051 | 0.064 | 0.065 | Lipocortins synthesis agonist | 0.065 0.027 DBMET00916 | DBMET00916 | |
| 0.051 | 0.066 | 0.071 | Transcription factor AP-1 inhibitor | 0.067 0.035 DB01024 0.071 0.029 DBMET00916 0.067 0.035 DBMET02606 | DBMET00916 | |
| 0.126 | 0.143 | 0.373 | Anesthetic general | 0.17 0.094 DB01024 0.154 0.109 DBMET00916 0.361 0.022 DBMET00918 0.373 0.02 DBMET00919 0.294 0.035 DBMET00920 0.17 0.094 DBMET02606 | DBMET00919 | |
| 0.067 | 0.088 | 0.078 | MAO B inhibitor | 0.078 0.077 DB01024 0.078 0.077 DBMET02606 | DBMET02606 | |
| 0.056 | 0.081 | 0.082 | HIV-1 integrase inhibitor | 0.069 0.049 DB01024 0.082 0.036 DBMET00918 0.069 0.049 DBMET02606 | DBMET00918 | |
| 0.093 | 0.118 | 0.178 | Toll-Like receptor 2 antagonist | 0.122 0.076 DB01024 0.171 0.039 DBMET00918 0.178 0.035 DBMET00919 0.122 0.076 DBMET02606 | DBMET00919 | |
| 0.043 | 0.069 | 0.082 | Alpha 1L adrenoreceptor antagonist | 0.052 0.036 DBMET00918 0.082 0.007 DBMET00919 | DBMET00919 | |
| 0.125 | 0.151 | 0.18 | Ca2+-transporting ATPase inhibitor | 0.15 0.044 DB01024 0.142 0.067 DBMET00916 0.178 0.008 DBMET00918 0.18 0.007 DBMET00919 0.159 0.025 DBMET00920 0.15 0.044 DBMET02606 | DBMET00919 | |
| 0.153 | 0.181 | 0.5 | Superoxide dismutase inhibitor | 0.233 0.087 DB01024 0.5 0.013 DBMET00918 0.482 0.015 DBMET00919 0.232 0.087 DBMET00920 0.233 0.087 DBMET02606 | DBMET00918 | |
| 0.075 | 0.104 | 0.141 | Interleukin 1 beta converting enzyme inhibitor | 0.089 0.074 DB01024 0.141 0.021 DBMET00918 0.132 0.027 DBMET00919 0.089 0.074 DBMET02606 | DBMET00918 | |
| 0.01 | 0.042 | 0.016 | DNA polymerase III polC-type inhibitor | 0.016 0.005 DBMET00919 | DBMET00919 | |
| 0.106 | 0.143 | 0.121 | Heat shock protein 90 antagonist | 0.121 0.112 DBMET00919 | DBMET00919 | |
| 0.019 | 0.057 | 0.03 | Retinoid X gamma receptor antagonist | 0.03 0.013 DB01024 0.03 0.013 DBMET02606 | DBMET02606 | |
| 0.118 | 0.156 | 0.191 | Interleukin antagonist | 0.191 0.089 DB01024 0.171 0.103 DBMET00916 0.191 0.089 DBMET02606 | DBMET02606 | |
| 0.099 | 0.138 | 0.438 | Diuretic | 0.255 0.03 DB01024 0.438 0.011 DBMET00916 0.21 0.041 DBMET00918 0.122 0.102 DBMET00919 0.255 0.03 DBMET02606 | DBMET00916 | |
| 0.076 | 0.116 | 0.277 | Anesthetic local | 0.161 0.044 DBMET00918 0.277 0.015 DBMET00919 | DBMET00919 | |
| 0.031 | 0.072 | 0.05 | Microtubule stabilization | 0.05 0.028 DBMET00916 | DBMET00916 | |
| 0.209 | 0.252 | 0.305 | MAP kinase kinase 6 inhibitor | 0.305 0.131 DBMET00919 | DBMET00919 | |
| 0.062 | 0.108 | 0.118 | Glutathione S-transferase inhibitor | 0.118 0.024 DB01024 0.087 0.051 DBMET00918 0.082 0.059 DBMET00919 0.074 0.072 DBMET00920 0.118 0.024 DBMET02606 | DBMET02606 | |
| 0.035 | 0.082 | 0.068 | HIV-1 integrase (Strand Transfer) inhibitor | 0.068 0.037 DB01024 0.068 0.037 DBMET02606 | DBMET02606 | |
| 0.083 | 0.133 | 0.129 | Cyclooxygenase 2 inhibitor | 0.129 0.071 DB01024 0.129 0.071 DBMET02606 | DBMET02606 | |
| 0.103 | 0.154 | 0.297 | NOS3 expression enhancer | 0.184 0.048 DB01024 0.297 0.018 DBMET00916 0.184 0.048 DBMET02606 | DBMET00916 | |
| 0.07 | 0.124 | 0.085 | T cell inhibitor | 0.085 0.048 DBMET00916 | DBMET00916 | |
| 0.034 | 0.09 | 0.088 | Leukotriene B4 antagonist | 0.076 0.017 DB01024 0.088 0.013 DBMET00916 0.076 0.017 DBMET02606 | DBMET00916 | |
| 0.011 | 0.069 | 0.02 | Leukotriene B4 receptor 2 antagonist | 0.02 0.019 DBMET00916 | DBMET00916 | |
| 0.03 | 0.088 | 0.06 | Maillard reaction inhibitor | 0.06 0.034 DB01024 0.06 0.034 DBMET02606 | DBMET02606 | |
| 0.011 | 0.07 | 0.024 | Leukotriene D4 antagonist | 0.024 0.021 DB01024 0.024 0.021 DBMET02606 | DBMET02606 | |
| 0.118 | 0.18 | 0.342 | Platelet aggregation inhibitor | 0.342 0.027 DBMET00918 | DBMET00918 | |
| 0.074 | 0.136 | 0.155 | Toll-Like receptor 4 antagonist | 0.096 0.076 DB01024 0.155 0.018 DBMET00916 0.108 0.058 DBMET00919 0.096 0.076 DBMET02606 | DBMET00916 | |
| 0.038 | 0.101 | 0.069 | HIV-1 integrase (3'-Processing) inhibitor | 0.069 0.04 DB01024 0.069 0.04 DBMET02606 | DBMET02606 | |
| 0.021 | 0.085 | 0.04 | Estrogen-related receptor beta antagonist | 0.04 0.011 DBMET00919 | DBMET00919 | |
| 0.027 | 0.093 | 0.094 | Protein 50S ribosomal subunit inhibitor | 0.094 0.015 DBMET00916 | DBMET00916 | |
| 0.062 | 0.128 | 0.1 | Gastric antisecretory | 0.1 0.066 DBMET00919 | DBMET00919 | |
| 0.019 | 0.087 | 0.033 | DNA polymerase III inhibitor | 0.033 0.009 DBMET00919 | DBMET00919 | |
| 0.04 | 0.111 | 0.058 | CDC25B inhibitor | 0.058 0.054 DB01024 0.058 0.054 DBMET02606 | DBMET02606 | |
| 0.009 | 0.082 | 0.031 | Leukotriene B4 receptor 1 antagonist | 0.031 0.017 DB01024 0.024 0.023 DBMET00916 0.031 0.017 DBMET02606 | DBMET02606 | |
| 0.076 | 0.153 | 0.178 | TRPA1 agonist | 0.178 0.016 DB01024 0.13 0.048 DBMET00916 0.178 0.016 DBMET02606 | DBMET02606 | |
| 0.069 | 0.146 | 0.157 | Beta glucuronidase inhibitor | 0.157 0.022 DBMET00916 | DBMET00916 | |
| 0.068 | 0.148 | 0.185 | Alkylator | 0.096 0.093 DB01024 0.185 0.031 DBMET00916 0.161 0.041 DBMET00918 0.166 0.039 DBMET00919 0.096 0.093 DBMET00920 0.096 0.093 DBMET02606 | DBMET00916 | |
| 0.004 | 0.085 | 0.053 | Peroxisome proliferator-activated receptor alpha antagonist | 0.053 0.008 DB01024 0.053 0.008 DBMET02606 | DBMET02606 | |
| 0.018 | 0.099 | 0.066 | Peroxisome proliferator-activated receptor alpha agonist | 0.066 0.024 DB01024 0.046 0.036 DBMET00918 0.066 0.024 DBMET02606 | DBMET02606 | |
| 0.142 | 0.225 | 0.2 | Transcription factor STAT3 inhibitor | 0.2 0.134 DBMET00918 | DBMET00918 | |
| 0.033 | 0.118 | 0.104 | Leukotriene antagonist | 0.104 0.02 DB01024 0.065 0.044 DBMET00916 0.104 0.02 DBMET02606 | DBMET02606 | |
| 0.049 | 0.133 | 0.228 | Interferon agonist | 0.193 0.006 DBMET00918 0.228 0.005 DBMET00919 | DBMET00919 | |
| 0.013 | 0.1 | 0.047 | Nicotinic acid receptor agonist | 0.047 0.016 DB01024 0.047 0.016 DBMET02606 | DBMET02606 | |
| 0.023 | 0.112 | 0.152 | Prostaglandin EP2 antagonist | 0.076 0.029 DB01024 0.073 0.031 DBMET00916 0.152 0.009 DBMET00918 0.076 0.029 DBMET02606 | DBMET00918 | |
| 0.102 | 0.192 | 0.139 | Antimitotic | 0.139 0.133 DB01024 0.139 0.133 DBMET02606 | DBMET02606 | |
| 0.047 | 0.139 | 0.092 | Exportin-1 inhibitor | 0.092 0.013 DBMET00918 0.083 0.022 DBMET00919 | DBMET00918 | |
| 0.095 | 0.191 | 0.317 | DNA methyltransferase I inhibitor | 0.207 0.066 DB01024 0.317 0.021 DBMET00916 0.301 0.026 DBMET00918 0.147 0.107 DBMET00919 0.207 0.066 DBMET02606 | DBMET00916 | |
| 0.006 | 0.112 | 0.028 | Prostaglandin EP2 agonist | 0.028 0.013 DBMET00918 0.026 0.014 DBMET00919 | DBMET00918 | |
| 0.066 | 0.174 | 0.135 | Phosphodiesterase 6D inhibitor | 0.11 0.036 DBMET00916 0.135 0.015 DBMET00919 | DBMET00919 | |
| 0.018 | 0.129 | 0.467 | Aldose reductase inhibitor | 0.06 0.032 DBMET00916 0.467 0.003 DBMET00918 | DBMET00918 | |
| 0.072 | 0.187 | 0.363 | Cell adhesion inhibitor | 0.105 0.081 DB01024 0.363 0.006 DBMET00916 0.143 0.051 DBMET00918 0.105 0.081 DBMET02606 | DBMET00916 | |
| 0.076 | 0.192 | 0.558 | Angiogenesis stimulant | 0.212 0.088 DB01024 0.558 0.009 DBMET00916 0.212 0.088 DBMET02606 | DBMET00916 | |
| 0.056 | 0.173 | 0.13 | Transcription factor NF kappa B stimulant | 0.078 0.075 DB01024 0.13 0.021 DBMET00916 0.078 0.075 DBMET02606 | DBMET00916 | |
| 0.012 | 0.13 | 0.029 | Cholesterol ester transfer protein antagonist | 0.029 0.026 DB01024 0.029 0.026 DBMET02606 | DBMET02606 | |
| 0.076 | 0.194 | 0.29 | Protein kinase stimulant | 0.17 0.055 DB01024 0.29 0.018 DBMET00916 0.11 0.104 DBMET00918 0.129 0.084 DBMET00919 0.17 0.055 DBMET02606 | DBMET00916 | |
| 0.024 | 0.143 | 0.062 | Glucagon-like peptide 1 agonist | 0.062 0.047 DB01024 0.062 0.047 DBMET02606 | DBMET02606 | |
| 0.039 | 0.158 | 0.165 | Interferon inducer | 0.14 0.005 DBMET00918 0.165 0.004 DBMET00919 | DBMET00919 | |
| 0.021 | 0.14 | 0.068 | Plasminogen activator inhibitor antagonist | 0.068 0.019 DB01024 0.054 0.028 DBMET00918 0.068 0.019 DBMET02606 | DBMET02606 | |
| 0.037 | 0.159 | 0.059 | Adenine nucleotide translocase inhibitor | 0.059 0.031 DBMET00916 | DBMET00916 | |
| 0.031 | 0.157 | 0.124 | Carbonic anhydrase XIII inhibitor | 0.103 0.036 DB01024 0.124 0.028 DBMET00916 0.103 0.036 DBMET02606 | DBMET00916 | |
| 0.009 | 0.142 | 0.135 | Dopamine D3 agonist | 0.037 0.031 DBMET00918 0.135 0.005 DBMET00919 | DBMET00919 | |
| 0.019 | 0.152 | 0.055 | Retinoid X receptor antagonist | 0.055 0.009 DB01024 0.035 0.032 DBMET00918 0.055 0.009 DBMET02606 | DBMET02606 | |
| 0.012 | 0.146 | 0.032 | Phosphodiesterase 6A inhibitor | 0.032 0.006 DBMET00919 | DBMET00919 | |
| 0.043 | 0.179 | 0.071 | Transcription factor RelA inhibitor | 0.071 0.028 DB01024 0.071 0.028 DBMET02606 | DBMET02606 | |
| 0.014 | 0.155 | 0.033 | Motilin receptor antagonist | 0.033 0.012 DBMET00919 | DBMET00919 | |
| 0.02 | 0.162 | 0.09 | Potassium channel (Inward rectifier) blocker | 0.09 0.009 DBMET00919 | DBMET00919 | |
| 0.073 | 0.222 | 0.192 | Dual specificity phosphatase 3 inhibitor | 0.192 0.066 DBMET00918 0.174 0.077 DBMET00919 | DBMET00918 | |
| 0.017 | 0.166 | 0.044 | Retinoid X alpha receptor antagonist | 0.044 0.011 DB01024 0.032 0.028 DBMET00918 0.044 0.011 DBMET02606 | DBMET02606 | |
| 0.031 | 0.184 | 0.096 | Androgen antagonist | 0.096 0.049 DB01024 0.091 0.054 DBMET00920 0.096 0.049 DBMET02606 | DBMET02606 | |
| 0.13 | 0.283 | 0.261 | Transcription factor STAT inhibitor | 0.261 0.079 DBMET00918 0.201 0.136 DBMET00919 | DBMET00918 | |
| 0.008 | 0.162 | 0.05 | Peroxisome proliferator-activated receptor delta agonist | 0.05 0.012 DBMET00918 | DBMET00918 | |
| 0.013 | 0.175 | 0.094 | GABA uptake inhibitor | 0.073 0.006 DBMET00918 0.094 0.004 DBMET00919 0.051 0.015 DBMET00920 | DBMET00919 | |
| 0.06 | 0.222 | 0.171 | Photosensitizer | 0.125 0.051 DB01024 0.171 0.021 DBMET00916 0.12 0.057 DBMET00918 0.103 0.082 DBMET00919 0.098 0.092 DBMET00920 0.125 0.051 DBMET02606 | DBMET00916 | |
| 0.032 | 0.201 | 0.077 | Histone deacetylase SIRT1 stimulant | 0.077 0.047 DBMET00919 | DBMET00919 | |
| 0.032 | 0.201 | 0.077 | Histone deacetylase stimulant | 0.077 0.047 DBMET00919 | DBMET00919 | |
| 0.123 | 0.294 | 0.435 | Vasodilator, peripheral | 0.388 0.059 DBMET00918 0.435 0.045 DBMET00919 0.297 0.098 DBMET00920 | DBMET00919 | |
| 0.035 | 0.208 | 0.073 | Leukotriene C antagonist | 0.056 0.041 DB01024 0.073 0.011 DBMET00918 0.056 0.041 DBMET02606 | DBMET00918 | |
| 0.002 | 0.175 | 0.015 | Lysophosphatidic acid receptor 3 agonist | 0.012 0.011 DBMET00918 0.015 0.008 DBMET00919 0.013 0.01 DBMET00920 | DBMET00919 | |
| 0.005 | 0.18 | 0.032 | Sphingosine 1-phosphate receptor 3 agonist | 0.032 0.026 DBMET00920 | DBMET00920 | |
| 0.023 | 0.203 | 0.125 | Phosphodiesterase 5A inhibitor | 0.125 0.017 DBMET00919 | DBMET00919 | |
| 0.177 | 0.358 | 0.504 | Caspase 9 stimulant | 0.34 0.154 DB01024 0.362 0.136 DBMET00916 0.504 0.058 DBMET00918 0.494 0.062 DBMET00919 0.334 0.159 DBMET00920 0.34 0.154 DBMET02606 | DBMET00918 | |
| 0.032 | 0.216 | 0.149 | Macrophage migration inhibitory factor inhibitor | 0.149 0.015 DBMET00918 0.109 0.03 DBMET00919 0.073 0.061 DBMET00920 | DBMET00918 | |
| 0.012 | 0.196 | 0.052 | Potassium channel Kv1.3 blocker | 0.052 0.028 DBMET00919 | DBMET00919 | |
| 0.022 | 0.211 | 0.049 | Leukotriene C4 antagonist | 0.049 0.011 DBMET00918 | DBMET00918 | |
| 0.049 | 0.24 | 0.288 | Thrombolytic | 0.146 0.085 DB01024 0.288 0.026 DBMET00916 0.209 0.048 DBMET00918 0.146 0.085 DBMET02606 | DBMET00916 | |
| 0.06 | 0.251 | 0.229 | Cholinergic | 0.229 0.035 DBMET00920 | DBMET00920 | |
| 0.12 | 0.312 | 0.241 | DNA directed DNA polymerase inhibitor | 0.241 0.197 DBMET00919 | DBMET00919 | |
| 0.006 | 0.199 | 0.033 | Retinoid X receptor agonist | 0.033 0.027 DB01024 0.031 0.028 DBMET00918 0.033 0.027 DBMET02606 | DBMET02606 | |
| 0.047 | 0.244 | 0.133 | Caspase 3 inhibitor | 0.107 0.08 DB01024 0.133 0.043 DBMET00918 0.107 0.08 DBMET02606 | DBMET00918 | |
| 0.021 | 0.218 | 0.121 | Phosphodiesterase V inhibitor | 0.121 0.018 DBMET00919 | DBMET00919 | |
| 0.073 | 0.273 | 0.312 | DNA methylase inhibitor | 0.18 0.093 DB01024 0.312 0.024 DBMET00916 0.282 0.034 DBMET00918 0.136 0.131 DBMET00919 0.18 0.093 DBMET02606 | DBMET00916 | |
| 0.015 | 0.216 | 0.027 | Toll-Like receptor 4 agonist | 0.027 0.016 DBMET00916 | DBMET00916 | |
| 0.044 | 0.25 | 0.095 | Thioredoxin inhibitor | 0.095 0.055 DBMET00916 | DBMET00916 | |
| 0.04 | 0.246 | 0.113 | Anabolic | 0.101 0.061 DB01024 0.113 0.046 DBMET00918 0.103 0.059 DBMET00919 0.097 0.067 DBMET00920 0.101 0.061 DBMET02606 | DBMET00918 | |
| 0.008 | 0.215 | 0.205 | Dopamine D5 antagonist | 0.205 0.005 DBMET00919 | DBMET00919 | |
| 0.072 | 0.281 | 0.737 | Aldehyde oxidase inhibitor | 0.533 0.028 DBMET00918 0.737 0.006 DBMET00919 0.413 0.045 DBMET00920 | DBMET00919 | |
| 0.025 | 0.235 | 0.092 | Bombesin 2 receptor antagonist | 0.092 0.015 DBMET00918 0.055 0.028 DBMET00919 | DBMET00918 | |
| 0.02 | 0.237 | 0.065 | Thromboxane synthase inhibitor | 0.065 0.021 DBMET00918 | DBMET00918 | |
| 0.089 | 0.308 | 0.308 | Cyclic AMP phosphodiesterase inhibitor | 0.246 0.066 DBMET00918 0.308 0.039 DBMET00919 | DBMET00919 | |
| 0.01 | 0.23 | 0.038 | Peroxisome proliferator-activated receptor delta antagonist | 0.038 0.017 DBMET00918 | DBMET00918 | |
| 0.038 | 0.263 | 0.209 | Cell adhesion molecule inhibitor | 0.209 0.009 DBMET00916 0.072 0.066 DBMET00918 | DBMET00916 | |
| 0.035 | 0.26 | 0.08 | ErbB-3 antagonist | 0.08 0.061 DBMET00918 | DBMET00918 | |
| 0.029 | 0.258 | 0.065 | Bcl2 antagonist | 0.065 0.049 DBMET00919 | DBMET00919 | |
| 0.001 | 0.23 | 0.008 | Mannitol 2-dehydrogenase inhibitor | 0.008 0.006 DBMET00919 | DBMET00919 | |
| 0.021 | 0.251 | 0.053 | Squalene epoxidase inhibitor | 0.053 0.028 DBMET00919 | DBMET00919 | |
| 0.005 | 0.239 | 0.145 | Leukotriene A4 hydrolase inhibitor | 0.092 0.007 DBMET00918 0.145 0.005 DBMET00919 | DBMET00919 | |
| 0.057 | 0.296 | 0.116 | Folate antagonist | 0.116 0.042 DBMET00920 | DBMET00920 | |
| 0.019 | 0.272 | 0.074 | Angiotensin-converting enzyme inhibitor | 0.074 0.016 DBMET00918 | DBMET00918 | |
| 0.007 | 0.262 | 0.024 | Prostaglandin F2 alpha agonist | 0.024 0.013 DBMET00918 0.021 0.019 DBMET00919 | DBMET00918 | |
| 0.008 | 0.264 | 0.04 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | 0.04 0.016 DBMET00918 | DBMET00918 | |
| 0.006 | 0.264 | 0.027 | Protocollagen prolyl hydroxylase inhibitor | 0.027 0.02 DBMET00918 | DBMET00918 | |
| 0.007 | 0.265 | 0.035 | Retinoid X alpha receptor agonist | 0.035 0.024 DB01024 0.035 0.024 DBMET02606 | DBMET02606 | |
| 0.016 | 0.274 | 0.057 | Antibiotic Aminoglycoside-like | 0.057 0.01 DBMET00916 | DBMET00916 | |
| 0.018 | 0.277 | 0.104 | Glucose-6-phosphate isomerase inhibitor | 0.049 0.031 DB01024 0.065 0.015 DBMET00916 0.104 0.004 DBMET00918 0.096 0.005 DBMET00919 0.089 0.007 DBMET00920 0.049 0.031 DBMET02606 | DBMET00918 | |
| 0.023 | 0.284 | 0.066 | Potassium channel intermediate-conductance Ca-activated blocker | 0.066 0.031 DBMET00918 0.066 0.031 DBMET00919 | DBMET00919 | |
| 0.059 | 0.323 | 0.442 | Interleukin agonist | 0.161 0.157 DBMET00916 0.379 0.022 DBMET00918 0.442 0.014 DBMET00919 0.229 0.095 DBMET00920 | DBMET00919 | |
| 0.013 | 0.282 | 0.089 | Dopamine agonist | 0.089 0.032 DBMET00919 | DBMET00919 | |
| 0.108 | 0.377 | 0.244 | ErbB-1 antagonist | 0.192 0.098 DBMET00918 0.244 0.055 DBMET00919 | DBMET00919 | |
| 0.047 | 0.324 | 0.097 | Estrogen-related receptor beta agonist | 0.09 0.041 DBMET00918 0.097 0.029 DBMET00919 0.086 0.05 DBMET00920 | DBMET00919 | |
| 0.007 | 0.285 | 0.025 | Lysophosphatidic acid receptor 1 agonist | 0.025 0.017 DBMET00918 0.025 0.017 DBMET00919 | DBMET00919 | |
| 0.077 | 0.357 | 0.164 | Lipocortins synthesis antagonist | 0.146 0.111 DB01024 0.164 0.087 DBMET00918 0.146 0.111 DBMET02606 | DBMET00918 | |
| 0.025 | 0.306 | 0.071 | Acetylcholine M3 receptor agonist | 0.071 0.07 DBMET00918 | DBMET00918 | |
| 0.118 | 0.399 | 0.372 | Interleukin 2 agonist | 0.223 0.152 DB01024 0.372 0.037 DBMET00916 0.257 0.111 DBMET00918 0.32 0.061 DBMET00919 0.223 0.152 DBMET02606 | DBMET00916 | |
| 0.014 | 0.297 | 0.05 | Cholesterol esterase inhibitor | 0.043 0.042 DBMET00918 0.05 0.029 DBMET00919 | DBMET00919 | |
| 0.03 | 0.315 | 0.219 | Keratolytic | 0.098 0.032 DB01024 0.073 0.06 DBMET00918 0.072 0.062 DBMET00919 0.219 0.007 DBMET00920 0.098 0.032 DBMET02606 | DBMET00920 | |
| 0.044 | 0.33 | 0.149 | Cytokine production inhibitor | 0.149 0.063 DBMET00919 | DBMET00919 | |
| 0.006 | 0.3 | 0.021 | Antibiotic Anthracycline-like | 0.021 0.01 DBMET00919 0.021 0.01 DBMET00920 | DBMET00920 | |
| 0.011 | 0.31 | 0.071 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.071 0.03 DBMET00918 | DBMET00918 | |
| 0.028 | 0.333 | 0.126 | Sphingomyelinase inhibitor | 0.126 0.037 DBMET00919 | DBMET00919 | |
| 0.007 | 0.312 | 0.023 | Protein 30S ribosomal subunit inhibitor | 0.023 0.018 DBMET00916 | DBMET00916 | |
| 0.016 | 0.321 | 0.057 | ATM kinase inhibitor | 0.039 0.018 DBMET00918 0.057 0.005 DBMET00919 | DBMET00919 | |
| 0.026 | 0.333 | 0.198 | EphA2 antagonist | 0.122 0.052 DBMET00918 0.198 0.014 DBMET00919 | DBMET00919 | |
| 0.041 | 0.349 | 0.133 | mTOR complex 1 inhibitor | 0.099 0.065 DBMET00918 0.133 0.018 DBMET00919 0.095 0.075 DBMET00920 | DBMET00919 | |
| 0.033 | 0.341 | 0.089 | Xanthine oxidase inhibitor | 0.089 0.072 DBMET00916 | DBMET00916 | |
| 0.022 | 0.332 | 0.047 | Phosphodiesterase 6C inhibitor | 0.047 0.029 DBMET00919 | DBMET00919 | |
| 0.01 | 0.322 | 0.167 | DNA-dependent protein kinase inhibitor | 0.059 0.015 DBMET00918 0.167 0.005 DBMET00919 0.037 0.032 DBMET00920 | DBMET00919 | |
| 0.011 | 0.325 | 0.279 | Selectin antagonist | 0.279 0.007 DBMET00916 | DBMET00916 | |
| 0.034 | 0.349 | 0.13 | Proteasome inhibitor | 0.103 0.084 DBMET00918 0.13 0.058 DBMET00919 | DBMET00919 | |
| 0.025 | 0.34 | 0.051 | DNA helicase inhibitor | 0.051 0.046 DBMET00918 | DBMET00918 | |
| 0.009 | 0.326 | 0.056 | Thromboxane antagonist | 0.056 0.036 DBMET00918 | DBMET00918 | |
| 0.007 | 0.326 | 0.052 | Thromboxane A2 antagonist | 0.052 0.034 DBMET00918 | DBMET00918 | |
| 0.015 | 0.336 | 0.145 | Sphingosine 1-phosphate receptor 5 agonist | 0.145 0.005 DBMET00918 0.058 0.029 DBMET00919 | DBMET00918 | |
| 0.082 | 0.411 | 0.168 | Catenin beta inhibitor | 0.168 0.07 DBMET00918 | DBMET00918 | |
| 0.005 | 0.336 | 0.081 | Fumarate hydratase inhibitor | 0.081 0.007 DBMET00918 0.04 0.019 DBMET00919 | DBMET00918 | |
| 0.073 | 0.41 | 0.243 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | 0.243 0.046 DBMET00919 | DBMET00919 | |
| 0.098 | 0.437 | 0.337 | Calcium channel activator | 0.328 0.066 DBMET00918 0.337 0.059 DBMET00919 | DBMET00919 | |
| 0.017 | 0.357 | 0.103 | Calcium antagonist | 0.103 0.045 DBMET00919 | DBMET00919 | |
| 0.015 | 0.356 | 0.079 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.079 0.052 DBMET00918 0.071 0.06 DBMET00919 | DBMET00918 | |
| 0.011 | 0.353 | 0.343 | Carbamoyl phosphate synthetase inhibitor | 0.259 0.005 DBMET00918 0.343 0.004 DBMET00919 0.154 0.011 DBMET00920 | DBMET00919 | |
| 0.005 | 0.347 | 0.034 | 5 Hydroxytryptamine 4 agonist | 0.028 0.009 DBMET00918 0.034 0.005 DBMET00919 | DBMET00919 | |
| 0.098 | 0.443 | 0.334 | Peptidyltransferase inhibitor | 0.334 0.015 DBMET00916 0.172 0.142 DBMET00918 0.209 0.088 DBMET00919 | DBMET00916 | |
| 0.002 | 0.348 | 0.031 | Prostaglandin H2 antagonist | 0.031 0.012 DBMET00918 | DBMET00918 | |
| 0.015 | 0.362 | 0.041 | Glutamate (mGluR8) antagonist | 0.041 0.015 DBMET00918 | DBMET00918 | |
| 0.004 | 0.353 | 0.022 | Isoleucine-tRNA ligase inhibitor | 0.021 0.02 DBMET00919 0.022 0.016 DBMET00920 | DBMET00920 | |
| 0.012 | 0.363 | 0.05 | Protein kinase C eta inhibitor | 0.05 0.043 DBMET00919 | DBMET00919 | |
| 0.012 | 0.364 | 0.211 | Catalase inhibitor | 0.19 0.017 DBMET00918 0.211 0.013 DBMET00919 0.102 0.038 DBMET00920 | DBMET00919 | |
| 0.076 | 0.43 | 0.219 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.154 0.141 DB01024 0.219 0.058 DBMET00918 0.197 0.074 DBMET00919 0.191 0.08 DBMET00920 0.154 0.141 DBMET02606 | DBMET00918 | |
| 0.014 | 0.371 | 0.109 | Dopamine D1 antagonist | 0.109 0.022 DBMET00919 | DBMET00919 | |
| 0.005 | 0.362 | 0.038 | DNA gyrase subunit B inhibitor | 0.038 0.027 DBMET00919 | DBMET00919 | |
| 0.01 | 0.372 | 0.069 | Lysophosphatidic acid 3 receptor antagonist | 0.069 0.015 DBMET00918 | DBMET00918 | |
| 0.011 | 0.374 | 0.279 | Alpha-mannosidase inhibitor | 0.142 0.004 DBMET00918 0.279 0.002 DBMET00919 0.088 0.009 DBMET00920 | DBMET00919 | |
| 0.024 | 0.392 | 0.188 | Prolactin inhibitor | 0.183 0.012 DBMET00918 0.188 0.011 DBMET00919 | DBMET00919 | |
| 0.014 | 0.383 | 0.173 | c-Src kinase inhibitor | 0.173 0.045 DBMET00919 | DBMET00919 | |
| 0.052 | 0.421 | 0.211 | Adenylate cyclase stimulant | 0.211 0.009 DBMET00918 0.167 0.038 DBMET00919 0.14 0.08 DBMET00920 | DBMET00918 | |
| 0.057 | 0.429 | 0.191 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.15 0.072 DBMET00918 0.191 0.024 DBMET00919 | DBMET00919 | |
| 0.024 | 0.397 | 0.237 | Psychostimulant | 0.233 0.065 DBMET00918 0.237 0.064 DBMET00919 | DBMET00919 | |
| 0.008 | 0.389 | 0.192 | Phosphofructokinase-1 inhibitor | 0.06 0.056 DB01024 0.114 0.027 DBMET00916 0.192 0.012 DBMET00918 0.162 0.016 DBMET00919 0.138 0.021 DBMET00920 0.06 0.056 DBMET02606 | DBMET00918 | |
| 0.004 | 0.386 | 0.175 | Purinergic P2Y12 antagonist | 0.175 0.004 DBMET00920 | DBMET00920 | |
| 0.007 | 0.391 | 0.041 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | 0.041 0.019 DBMET00919 | DBMET00919 | |
| 0.031 | 0.43 | 0.137 | mTOR complex 2 inhibitor | 0.109 0.025 DBMET00918 0.137 0.011 DBMET00919 0.098 0.035 DBMET00920 | DBMET00919 | |
| 0.017 | 0.417 | 0.071 | Cathepsin G inhibitor | 0.071 0.053 DBMET00918 | DBMET00918 | |
| 0.007 | 0.409 | 0.035 | Toll-Like receptor 2 agonist | 0.035 0.034 DBMET00918 | DBMET00918 | |
| 0.044 | 0.448 | 0.306 | Succinate dehydrogenase inhibitor | 0.179 0.069 DB01024 0.306 0.01 DBMET00918 0.272 0.016 DBMET00919 0.233 0.029 DBMET00920 0.179 0.069 DBMET02606 | DBMET00918 | |
| 0.02 | 0.433 | 0.157 | Cystathionine beta-synthase inhibitor | 0.157 0.038 DBMET00918 0.104 0.073 DBMET00919 0.094 0.085 DBMET00920 | DBMET00918 | |
| 0.007 | 0.423 | 0.229 | Mannosidase inhibitor | 0.117 0.005 DBMET00918 0.229 0.003 DBMET00919 0.077 0.009 DBMET00920 | DBMET00919 | |
| 0.004 | 0.423 | 0.028 | Potassium channel subfamily K member 3 blocker | 0.028 0.025 DBMET00919 | DBMET00919 | |
| 0.004 | 0.423 | 0.169 | GP IIb/IIIa receptor antagonist | 0.169 0.009 DBMET00918 | DBMET00918 | |
| 0.003 | 0.424 | 0.032 | Sodium/glucose cotransporter 2 inhibitor | 0.032 0.011 DBMET00916 0.024 0.023 DBMET00919 | DBMET00916 | |
| 0.013 | 0.446 | 0.074 | Beta adrenoreceptor antagonist | 0.074 0.033 DBMET00919 | DBMET00919 | |
| 0.02 | 0.455 | 0.16 | Glutamate dehydrogenase inhibitor | 0.16 0.014 DBMET00918 0.095 0.034 DBMET00919 0.072 0.053 DBMET00920 | DBMET00918 | |
| 0.017 | 0.453 | 0.039 | Integrin alpha1beta1 antagonist | 0.039 0.024 DBMET00918 | DBMET00918 | |
| 0.004 | 0.446 | 0.096 | Calcium-sensing receptor agonist | 0.096 0.003 DBMET00918 0.07 0.004 DBMET00919 | DBMET00918 | |
| 0.018 | 0.463 | 0.344 | Creatine kinase inhibitor | 0.322 0.004 DBMET00918 0.344 0.004 DBMET00919 0.178 0.015 DBMET00920 | DBMET00919 | |
| 0.061 | 0.507 | 0.163 | MAP kinase kinase 4 inhibitor | 0.163 0.041 DBMET00919 | DBMET00919 | |
| 0.001 | 0.45 | 0.018 | Carbonic anhydrase VIII inhibitor | 0.018 0.01 DBMET00918 | DBMET00918 | |
| 0.001 | 0.45 | 0.018 | Carbonic anhydrase X inhibitor | 0.018 0.01 DBMET00918 | DBMET00918 | |
| 0.017 | 0.466 | 0.115 | Caspase 7 inhibitor | 0.11 0.02 DBMET00918 0.115 0.017 DBMET00919 | DBMET00919 | |
| 0.006 | 0.458 | 0.026 | Toll-Like receptor 8 agonist | 0.026 0.006 DBMET00919 0.026 0.006 DBMET00920 | DBMET00920 | |
| 0.013 | 0.47 | 0.049 | Aldosterone antagonist | 0.049 0.031 DBMET00919 | DBMET00919 | |
| 0.044 | 0.502 | 0.236 | Phospholipase C inhibitor | 0.191 0.051 DBMET00918 0.185 0.055 DBMET00919 0.236 0.028 DBMET00920 | DBMET00920 | |
| 0.005 | 0.464 | 0.063 | Prostaglandin-E synthase inhibitor | 0.063 0.058 DB01024 0.063 0.058 DBMET02606 | DBMET02606 | |
| 0.014 | 0.475 | 0.128 | Antiadrenergic | 0.128 0.042 DBMET00919 | DBMET00919 | |
| 0.018 | 0.48 | 0.165 | Src kinase inhibitor | 0.165 0.074 DBMET00919 | DBMET00919 | |
| 0.014 | 0.475 | 0.126 | Adrenaline antagonist | 0.126 0.042 DBMET00919 | DBMET00919 | |
| 0.027 | 0.489 | 0.086 | Granulocyte macrophage colony stimulating factor agonist | 0.086 0.06 DBMET00918 0.082 0.071 DBMET00919 | DBMET00918 | |
| 0.017 | 0.479 | 0.279 | Toll-Like receptor 9 antagonist | 0.166 0.053 DBMET00918 0.279 0.016 DBMET00919 | DBMET00919 | |
| 0.012 | 0.476 | 0.062 | Kainate receptor agonist | 0.062 0.006 DBMET00918 0.043 0.025 DBMET00919 0.04 0.031 DBMET00920 | DBMET00918 | |
| 0.017 | 0.483 | 0.108 | AXL receptor tyrosine kinase inhibitor | 0.108 0.033 DBMET00919 | DBMET00919 | |
| 0.041 | 0.508 | 0.101 | Glutamate release inhibitor | 0.101 0.042 DBMET00918 0.089 0.064 DBMET00919 | DBMET00918 | |
| 0.066 | 0.535 | 0.457 | 5 Hydroxytryptamine release stimulant | 0.401 0.046 DBMET00918 0.457 0.035 DBMET00919 0.252 0.088 DBMET00920 | DBMET00919 | |
| 0.002 | 0.476 | 0.017 | Telomerase stimulant | 0.017 0.012 DBMET00918 | DBMET00918 | |
| 0.013 | 0.493 | 0.091 | Glycine receptor antagonist | 0.091 0.042 DBMET00916 0.083 0.052 DBMET00918 | DBMET00916 | |
| 0.013 | 0.495 | 0.092 | Heat shock protein 90 beta antagonist | 0.092 0.014 DBMET00919 | DBMET00919 | |
| 0.017 | 0.502 | 0.121 | GABA receptor agonist | 0.121 0.055 DBMET00919 | DBMET00919 | |
| 0.054 | 0.544 | 0.584 | Toll-Like receptor agonist | 0.584 0.019 DBMET00918 | DBMET00918 | |
| 0.007 | 0.497 | 0.061 | Dopamine uptake inhibitor | 0.061 0.037 DBMET00919 | DBMET00919 | |
| 0.005 | 0.498 | 0.475 | Prostaglandin antagonist | 0.475 0.004 DBMET00918 | DBMET00918 | |
| 0.028 | 0.529 | 0.251 | Amyloid beta precursor protein antagonist | 0.251 0.032 DBMET00919 | DBMET00919 | |
| 0.017 | 0.519 | 0.124 | Ephrin antagonist | 0.124 0.048 DBMET00919 | DBMET00919 | |
| 0.008 | 0.509 | 0.057 | Ceramide glucosyltransferase inhibitor | 0.045 0.011 DBMET00918 0.057 0.004 DBMET00919 0.041 0.016 DBMET00920 | DBMET00919 | |
| 0.036 | 0.541 | 0.178 | Transcription factor STAT6 inhibitor | 0.178 0.01 DBMET00918 0.17 0.013 DBMET00919 | DBMET00918 | |
| 0.051 | 0.561 | 0.589 | Toll-Like receptor 7 agonist | 0.589 0.019 DBMET00918 | DBMET00918 | |
| 0.01 | 0.52 | 0.093 | Cytokine production stimulant | 0.057 0.015 DBMET00918 0.093 0.004 DBMET00919 0.057 0.017 DBMET00920 | DBMET00919 | |
| 0.008 | 0.521 | 0.038 | Protein kinase C beta I inhibitor | 0.038 0.011 DBMET00919 | DBMET00919 | |
| 0.008 | 0.522 | 0.139 | Histidine decarboxylase inhibitor | 0.139 0.021 DBMET00918 0.066 0.054 DBMET00919 | DBMET00918 | |
| 0.004 | 0.518 | 0.026 | Sodium/glucose cotransporter inhibitor | 0.026 0.017 DBMET00916 0.025 0.018 DBMET00919 | DBMET00916 | |
| 0.008 | 0.524 | 0.141 | Glutamate decarboxylase inhibitor | 0.141 0.015 DBMET00918 0.103 0.028 DBMET00919 0.095 0.033 DBMET00920 | DBMET00918 | |
| 0.004 | 0.521 | 0.057 | Dopamine D2 agonist | 0.057 0.023 DBMET00919 | DBMET00919 | |
| 0.023 | 0.542 | 0.129 | Acetylcholine release stimulant | 0.116 0.055 DBMET00918 0.129 0.035 DBMET00919 0.108 0.07 DBMET00920 | DBMET00919 | |
| 0.02 | 0.539 | 0.218 | Anticoagulant | 0.126 0.105 DBMET00916 0.217 0.047 DBMET00918 0.218 0.047 DBMET00920 | DBMET00920 | |
| 0.033 | 0.554 | 0.187 | GABA C receptor rho-2 antagonist | 0.187 0.037 DBMET00918 0.181 0.041 DBMET00919 0.161 0.06 DBMET00920 | DBMET00918 | |
| 0.012 | 0.535 | 0.058 | Carnitine palmitoyltransferase 1B inhibitor | 0.058 0.02 DBMET00918 | DBMET00918 | |
| 0.031 | 0.558 | 0.2 | Antipruritic | 0.2 0.049 DBMET00919 | DBMET00919 | |
| 0.002 | 0.529 | 0.062 | Kynurenine 3 monooxygenase inhibitor | 0.062 0.005 DBMET00918 | DBMET00918 | |
| 0.006 | 0.535 | 0.044 | Estrogen-related receptor gamma antagonist | 0.03 0.017 DBMET00918 0.044 0.004 DBMET00919 0.033 0.011 DBMET00920 | DBMET00919 | |
| 0.01 | 0.539 | 0.075 | Beta 2 adrenoreceptor agonist | 0.064 0.034 DBMET00918 0.075 0.013 DBMET00919 | DBMET00919 | |
| 0.01 | 0.542 | 0.111 | Hepatocyte growth factor antagonist | 0.111 0.042 DBMET00919 | DBMET00919 | |
| 0.017 | 0.557 | 0.251 | Toll-Like receptor antagonist | 0.133 0.069 DBMET00918 0.251 0.015 DBMET00919 | DBMET00919 | |
| 0.006 | 0.546 | 0.078 | Epoxide hydrolase inhibitor | 0.071 0.052 DBMET00918 0.078 0.044 DBMET00919 | DBMET00919 | |
| 0.023 | 0.564 | 0.121 | Aldehyde dehydrogenase inhibitor | 0.119 0.072 DBMET00918 0.116 0.075 DBMET00919 0.121 0.07 DBMET00920 | DBMET00920 | |
| 0.005 | 0.546 | 0.056 | Fibroblast growth factor 4 antagonist | 0.056 0.043 DBMET00919 | DBMET00919 | |
| 0.014 | 0.558 | 0.161 | HERG channel blocker | 0.161 0.12 DBMET00919 | DBMET00919 | |
| 0.01 | 0.557 | 0.08 | GABA A receptor agonist | 0.08 0.064 DBMET00919 | DBMET00919 | |
| 0.004 | 0.551 | 0.085 | LFA antagonist | 0.085 0.004 DBMET00918 0.04 0.008 DBMET00919 | DBMET00918 | |
| 0.014 | 0.563 | 0.418 | GABA C receptor agonist | 0.418 0.005 DBMET00918 0.225 0.016 DBMET00919 0.251 0.013 DBMET00920 | DBMET00918 | |
| 0.013 | 0.562 | 0.066 | Ryanodine receptor antagonist | 0.066 0.024 DBMET00918 0.059 0.041 DBMET00919 | DBMET00918 | |
| 0.007 | 0.558 | 0.07 | Beta 1 adrenoreceptor antagonist | 0.07 0.026 DBMET00919 | DBMET00919 | |
| 0.013 | 0.567 | 0.051 | Autotaxin inhibitor | 0.049 0.043 DBMET00918 0.051 0.04 DBMET00919 | DBMET00919 | |
| 0.001 | 0.555 | 0.011 | Glutamate (mGluR6) agonist | 0.011 0.01 DBMET00918 | DBMET00918 | |
| 0.002 | 0.557 | 0.049 | Phosphoglycerate kinase inhibitor | 0.039 0.02 DBMET00918 0.049 0.014 DBMET00919 0.037 0.022 DBMET00920 | DBMET00919 | |
| 0.01 | 0.565 | 0.089 | GABA aminotransferase inhibitor | 0.089 0.036 DBMET00918 | DBMET00918 | |
| 0.018 | 0.574 | 0.102 | Glutamate (mGluR6) antagonist | 0.102 0.01 DBMET00918 0.08 0.024 DBMET00919 0.087 0.018 DBMET00920 | DBMET00918 | |
| 0.009 | 0.565 | 0.064 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.064 0.026 DBMET00919 0.057 0.033 DBMET00920 | DBMET00919 | |
| 0.014 | 0.574 | 0.149 | Potassium channel (Voltage-sensitive) blocker | 0.149 0.138 DBMET00919 | DBMET00919 | |
| 0.036 | 0.599 | 0.178 | DNA repair enzyme inhibitor | 0.178 0.014 DBMET00918 0.169 0.018 DBMET00919 0.136 0.047 DBMET00920 | DBMET00918 | |
| 0.024 | 0.588 | 0.122 | Nav1.1 sodium channel blocker | 0.122 0.047 DBMET00919 | DBMET00919 | |
| 0.003 | 0.569 | 0.045 | Dopamine D5 agonist | 0.045 0.022 DBMET00918 0.045 0.021 DBMET00919 | DBMET00919 | |
| 0.019 | 0.587 | 0.248 | Triose-phosphate isomerase inhibitor | 0.089 0.061 DBMET00916 0.248 0.007 DBMET00918 0.21 0.01 DBMET00919 0.158 0.018 DBMET00920 | DBMET00918 | |
| 0.025 | 0.596 | 0.247 | MAP3K9 inhibitor | 0.247 0.005 DBMET00919 | DBMET00919 | |
| 0.001 | 0.575 | 0.014 | Egl nine homolog 3 inhibitor | 0.014 0.006 DBMET00918 | DBMET00918 | |
| 0.005 | 0.58 | 0.042 | Glycine transporter 2 inhibitor | 0.041 0.037 DBMET00918 0.042 0.037 DBMET00919 | DBMET00919 | |
| 0.016 | 0.592 | 0.085 | Phosphodiesterase VIII inhibitor | 0.085 0.027 DBMET00919 | DBMET00919 | |
| 0.001 | 0.578 | 0.066 | Arginase inhibitor | 0.066 0.009 DBMET00918 0.052 0.014 DBMET00919 | DBMET00918 | |
| 0.004 | 0.582 | 0.201 | Alcohol oxidase inhibitor | 0.201 0.006 DBMET00918 0.161 0.009 DBMET00919 0.099 0.018 DBMET00920 | DBMET00918 | |
| 0.005 | 0.583 | 0.021 | Methylmalonyl-CoA mutase inhibitor | 0.021 0.007 DBMET00918 0.019 0.01 DBMET00919 | DBMET00918 | |
| 0.015 | 0.593 | 0.12 | Alpha 2c adrenoreceptor antagonist | 0.12 0.05 DBMET00919 | DBMET00919 | |
| 0.006 | 0.585 | 0.206 | Porphobilinogen synthase inhibitor | 0.206 0.011 DBMET00918 0.09 0.041 DBMET00919 | DBMET00918 | |
| 0.006 | 0.586 | 0.042 | Membrane dipeptidase inhibitor | 0.042 0.024 DBMET00918 | DBMET00918 | |
| 0.001 | 0.581 | 0.05 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.035 0.015 DBMET00918 0.05 0.009 DBMET00919 0.031 0.017 DBMET00920 | DBMET00919 | |
| 0.015 | 0.596 | 0.343 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | 0.103 0.098 DBMET00918 0.343 0.011 DBMET00919 | DBMET00919 | |
| 0.023 | 0.605 | 0.146 | Thiol protease inhibitor | 0.146 0.073 DBMET00918 0.132 0.092 DBMET00919 | DBMET00918 | |
| 0.005 | 0.591 | 0.05 | Phosphatidylinositol 3-kinase delta inhibitor | 0.05 0.046 DBMET00919 | DBMET00919 | |
| 0.005 | 0.592 | 0.045 | Protein kinase C beta II inhibitor | 0.045 0.008 DBMET00919 | DBMET00919 | |
| 0.017 | 0.605 | 0.209 | Acetylcholine M1 receptor antagonist | 0.12 0.109 DBMET00918 0.209 0.039 DBMET00919 | DBMET00919 | |
| 0.005 | 0.593 | 0.108 | Acetylcholine M5 receptor agonist | 0.059 0.056 DBMET00918 0.108 0.016 DBMET00919 0.059 0.057 DBMET00920 | DBMET00919 | |
| 0.003 | 0.591 | 0.071 | Guanylate cyclase inhibitor | 0.071 0.005 DBMET00918 0.07 0.005 DBMET00919 0.064 0.008 DBMET00920 | DBMET00918 | |
| 0.029 | 0.619 | 0.248 | Adenylate kinase inhibitor | 0.248 0.01 DBMET00918 0.172 0.02 DBMET00919 0.127 0.038 DBMET00920 | DBMET00918 | |
| 0.02 | 0.613 | 0.228 | NADH dehydrogenase inhibitor | 0.228 0.009 DBMET00918 0.205 0.01 DBMET00919 0.143 0.019 DBMET00920 | DBMET00918 | |
| 0.015 | 0.608 | 0.605 | Alpha-N-acetylglucosaminidase inhibitor | 0.605 0.004 DBMET00918 0.529 0.005 DBMET00919 0.448 0.007 DBMET00920 | DBMET00918 | |
| 0.024 | 0.619 | 0.319 | Peroxidase inhibitor | 0.319 0.034 DBMET00918 0.309 0.036 DBMET00919 0.169 0.069 DBMET00920 | DBMET00918 | |
| 0.017 | 0.615 | 0.165 | Calpain inhibitor | 0.165 0.156 DBMET00918 | DBMET00918 | |
| 0.005 | 0.603 | 0.1 | Histamine H1 receptor antagonist | 0.1 0.041 DBMET00919 | DBMET00919 | |
| 0.014 | 0.612 | 0.137 | Phosphodiesterase 1C inhibitor | 0.058 0.055 DBMET00918 0.137 0.005 DBMET00919 | DBMET00919 | |
| 0.004 | 0.603 | 0.156 | Acyl-CoA dehydrogenase inhibitor | 0.156 0.008 DBMET00918 0.123 0.012 DBMET00919 0.079 0.022 DBMET00920 | DBMET00918 | |
| 0.013 | 0.613 | 0.126 | Epidermal growth factor receptor kinase inhibitor | 0.126 0.067 DBMET00919 | DBMET00919 | |
| 0.002 | 0.603 | 0.05 | Geranyltranstransferase inhibitor | 0.05 0.023 DBMET00918 | DBMET00918 | |
| 0.004 | 0.605 | 0.081 | 5 Hydroxytryptamine 4 antagonist | 0.081 0.013 DBMET00919 | DBMET00919 | |
| 0.015 | 0.617 | 0.15 | Aminopeptidase B inhibitor | 0.15 0.038 DBMET00918 0.118 0.053 DBMET00919 0.123 0.051 DBMET00920 | DBMET00918 | |
| 0.001 | 0.603 | 0.023 | CXC chemokine 4 receptor agonist | 0.023 0.005 DBMET00918 0.023 0.005 DBMET00919 | DBMET00919 | |
| 0.006 | 0.611 | 0.1 | Aconitate hydratase inhibitor | 0.1 0.008 DBMET00918 0.061 0.025 DBMET00919 0.055 0.031 DBMET00920 | DBMET00918 | |
| 0.055 | 0.663 | 0.409 | 5 Hydroxytryptamine release inhibitor | 0.407 0.073 DBMET00918 0.409 0.073 DBMET00919 0.302 0.163 DBMET00920 | DBMET00919 | |
| 0.006 | 0.616 | 0.075 | Phosphatidylinositol 3-kinase gamma inhibitor | 0.075 0.022 DBMET00919 | DBMET00919 | |
| 0.005 | 0.618 | 0.034 | Glutamate (mGluR3) agonist | 0.034 0.019 DBMET00918 | DBMET00918 | |
| 0.008 | 0.621 | 0.06 | Dopamine beta hydroxylase inhibitor | 0.06 0.015 DBMET00918 0.058 0.017 DBMET00919 | DBMET00918 | |
| 0.008 | 0.622 | 0.05 | Glutamate (mGluR8) agonist | 0.05 0.011 DBMET00918 0.036 0.032 DBMET00919 | DBMET00918 | |
| 0.012 | 0.627 | 0.1 | GABA B receptor agonist | 0.1 0.016 DBMET00918 0.087 0.029 DBMET00919 0.074 0.056 DBMET00920 | DBMET00918 | |
| 0.001 | 0.618 | 0.016 | Egl nine homolog 1 inhibitor | 0.016 0.008 DBMET00918 | DBMET00918 | |
| 0.008 | 0.625 | 0.13 | Protein kinase C beta inhibitor | 0.08 0.03 DBMET00918 0.13 0.005 DBMET00919 | DBMET00919 | |
| 0.017 | 0.636 | 0.242 | Adenylate cyclase inhibitor | 0.157 0.041 DBMET00918 0.242 0.02 DBMET00919 | DBMET00919 | |
| 0.007 | 0.63 | 0.109 | Phosphatidylinositol kinase inhibitor | 0.109 0.019 DBMET00919 | DBMET00919 | |
| 0.003 | 0.626 | 0.035 | Nociceptin (N/OFQ) receptor antagonist | 0.035 0.025 DBMET00919 | DBMET00919 | |
| 0.009 | 0.635 | 0.104 | Potassium channel (Tandem pore domain) blocker | 0.083 0.028 DBMET00918 0.104 0.007 DBMET00919 0.072 0.058 DBMET00920 | DBMET00919 | |
| 0.004 | 0.632 | 0.131 | Phosphatidylinositol 3-kinase alpha inhibitor | 0.131 0.012 DBMET00919 | DBMET00919 | |
| 0.012 | 0.643 | 0.161 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.161 0.13 DBMET00918 | DBMET00918 | |
| 0.013 | 0.645 | 0.081 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | 0.081 0.063 DBMET00919 | DBMET00919 | |
| 0.066 | 0.698 | 0.134 | Heat shock protein 70 antagonist | 0.134 0.1 DBMET00918 0.129 0.125 DBMET00919 | DBMET00918 | |
| 0.009 | 0.644 | 0.039 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.039 0.035 DBMET00920 | DBMET00920 | |
| 0.004 | 0.64 | 0.175 | Biliverdin reductase inhibitor | 0.175 0.007 DBMET00918 0.107 0.017 DBMET00919 0.065 0.036 DBMET00920 | DBMET00918 | |
| 0.071 | 0.711 | 0.259 | 5 Hydroxytryptamine uptake stimulant | 0.259 0.072 DBMET00918 0.214 0.127 DBMET00919 0.21 0.133 DBMET00920 | DBMET00918 | |
| 0.017 | 0.66 | 0.145 | Phosphodiesterase I inhibitor | 0.093 0.054 DBMET00918 0.145 0.018 DBMET00919 | DBMET00919 | |
| 0.014 | 0.658 | 0.122 | Phosphodiesterase 1B inhibitor | 0.122 0.01 DBMET00919 | DBMET00919 | |
| 0.008 | 0.653 | 0.027 | Hedgehog signaling activator | 0.027 0.021 DBMET00919 | DBMET00919 | |
| 0.042 | 0.693 | 0.281 | MAP-kinase-activated kinase 5 inhibitor | 0.281 0.041 DBMET00919 | DBMET00919 | |
| 0.01 | 0.662 | 0.192 | Anticonvulsant | 0.181 0.098 DBMET00918 0.192 0.088 DBMET00919 | DBMET00919 | |
| 0.012 | 0.665 | 0.153 | GABA C receptor rho-1 antagonist | 0.153 0.02 DBMET00918 0.128 0.034 DBMET00919 0.113 0.047 DBMET00920 | DBMET00918 | |
| 0.005 | 0.658 | 0.114 | Tyrosine-protein kinase receptor FLT3 inhibitor | 0.114 0.071 DBMET00919 | DBMET00919 | |
| 0.007 | 0.661 | 0.068 | Adenosine deaminase inhibitor | 0.051 0.029 DBMET00918 0.068 0.015 DBMET00919 0.048 0.032 DBMET00920 | DBMET00919 | |
| 0.007 | 0.662 | 0.041 | Adenosine uptake inhibitor | 0.035 0.024 DBMET00918 0.041 0.011 DBMET00919 | DBMET00919 | |
| 0.004 | 0.662 | 0.03 | ICAM 1 antagonist | 0.03 0.007 DBMET00918 0.024 0.014 DBMET00919 | DBMET00918 | |
| 0.012 | 0.67 | 0.06 | Nicotinic alpha3beta2 receptor antagonist | 0.06 0.026 DBMET00919 | DBMET00919 | |
| 0.014 | 0.675 | 0.212 | Calpain 2 inhibitor | 0.212 0.177 DBMET00918 0.203 0.184 DBMET00919 | DBMET00918 | |
| 0.01 | 0.671 | 0.091 | Myeloperoxidase inhibitor | 0.091 0.047 DBMET00919 | DBMET00919 | |
| 0.009 | 0.67 | 0.141 | Acetylcholine muscarinic antagonist | 0.141 0.049 DBMET00919 | DBMET00919 | |
| 0.015 | 0.677 | 0.131 | Pregnane X receptor agonist | 0.123 0.121 DBMET00918 0.131 0.098 DBMET00919 | DBMET00919 | |
| 0 | 0.663 | 0.013 | Integrin alpha5beta6 antagonist | 0.013 0.003 DBMET00918 0.007 0.004 DBMET00919 | DBMET00918 | |
| 0.01 | 0.673 | 0.094 | CC chemokine 4 receptor antagonist | 0.078 0.007 DBMET00918 0.094 0.005 DBMET00919 | DBMET00919 | |
| 0.01 | 0.675 | 0.127 | Cholinergic antagonist | 0.127 0.067 DBMET00919 | DBMET00919 | |
| 0.008 | 0.675 | 0.101 | Phospholipase D inhibitor | 0.093 0.019 DBMET00918 0.101 0.014 DBMET00919 | DBMET00919 | |
| 0.009 | 0.677 | 0.182 | GABA C receptor antagonist | 0.182 0.017 DBMET00918 0.156 0.027 DBMET00919 0.149 0.031 DBMET00920 | DBMET00918 | |
| 0.006 | 0.677 | 0.119 | Aminopeptidase I inhibitor | 0.119 0.02 DBMET00918 0.103 0.026 DBMET00919 0.085 0.037 DBMET00920 | DBMET00918 | |
| 0.006 | 0.679 | 0.071 | Adenylate cyclase 1 inhibitor | 0.071 0.012 DBMET00919 | DBMET00919 | |
| 0.002 | 0.676 | 0.053 | Sphingosine 1-phosphate receptor 1 agonist | 0.053 0.017 DBMET00918 0.047 0.023 DBMET00919 | DBMET00918 | |
| 0.001 | 0.675 | 0.022 | Dopamine autoreceptor agonist | 0.022 0.018 DBMET00919 | DBMET00919 | |
| 0.021 | 0.696 | 0.099 | D-Ala-D-Ala ligase inhibitor | 0.099 0.03 DBMET00918 0.087 0.051 DBMET00919 | DBMET00918 | |
| 0.004 | 0.681 | 0.087 | Sphingosine kinase inhibitor | 0.087 0.012 DBMET00919 0.055 0.049 DBMET00920 | DBMET00919 | |
| 0.007 | 0.685 | 0.085 | Glutamate (mGluR7) antagonist | 0.085 0.022 DBMET00918 0.063 0.058 DBMET00920 | DBMET00918 | |
| 0.003 | 0.682 | 0.054 | Cannabinoid CB2 receptor antagonist | 0.054 0.034 DBMET00919 | DBMET00919 | |
| 0.004 | 0.684 | 0.126 | Protein kinase C zeta inhibitor | 0.126 0.029 DBMET00919 | DBMET00919 | |
| 0.007 | 0.688 | 0.201 | Protein kinase C gamma inhibitor | 0.106 0.068 DBMET00918 0.201 0.014 DBMET00919 | DBMET00919 | |
| 0.004 | 0.687 | 0.077 | Phosphatidylinositol 3-kinase beta inhibitor | 0.077 0.018 DBMET00919 | DBMET00919 | |
| 0.005 | 0.689 | 0.051 | p53 inhibitor | 0.051 0.014 DBMET00918 | DBMET00918 | |
| 0.031 | 0.715 | 0.309 | Insulysin inhibitor | 0.309 0.053 DBMET00918 0.254 0.093 DBMET00919 0.207 0.147 DBMET00920 | DBMET00918 | |
| 0.024 | 0.714 | 0.228 | Hexokinase inhibitor | 0.192 0.04 DBMET00918 0.228 0.023 DBMET00919 | DBMET00919 | |
| 0.01 | 0.701 | 0.207 | Mannose-6-phosphate isomerase inhibitor | 0.154 0.061 DBMET00918 0.207 0.027 DBMET00919 0.114 0.113 DBMET00920 | DBMET00919 | |
| 0.003 | 0.694 | 0.386 | Prostaglandin D2 antagonist | 0.386 0.003 DBMET00918 | DBMET00918 | |
| 0.015 | 0.707 | 0.194 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.194 0.017 DBMET00918 0.129 0.035 DBMET00919 0.091 0.065 DBMET00920 | DBMET00918 | |
| 0.002 | 0.699 | 0.03 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.026 0.006 DBMET00918 0.03 0.004 DBMET00919 | DBMET00919 | |
| 0.015 | 0.712 | 0.098 | MAP kinase kinase 7 inhibitor | 0.084 0.037 DBMET00918 0.098 0.015 DBMET00919 0.084 0.036 DBMET00920 | DBMET00919 | |
| 0.005 | 0.701 | 0.066 | EphB4 antagonist | 0.066 0.033 DBMET00919 | DBMET00919 | |
| 0.001 | 0.698 | 0.044 | Integrin beta2 antagonist | 0.044 0.003 DBMET00918 0.018 0.005 DBMET00919 | DBMET00918 | |
| 0.03 | 0.727 | 0.401 | MAP kinase 1 inhibitor | 0.401 0.105 DBMET00919 | DBMET00919 | |
| 0.007 | 0.705 | 0.094 | ErbB-2 antagonist | 0.094 0.038 DBMET00919 | DBMET00919 | |
| 0.01 | 0.708 | 0.227 | UDP-glucose 4-epimerase inhibitor | 0.176 0.022 DBMET00918 0.227 0.015 DBMET00919 0.16 0.026 DBMET00920 | DBMET00919 | |
| 0.002 | 0.7 | 0.027 | Acetylcholine M4 receptor agonist | 0.027 0.025 DBMET00919 | DBMET00919 | |
| 0.002 | 0.701 | 0.087 | Ornithine carbamoyltransferase inhibitor | 0.087 0.019 DBMET00918 0.071 0.025 DBMET00919 0.059 0.032 DBMET00920 | DBMET00918 | |
| 0.002 | 0.701 | 0.04 | Methionyl aminopeptidase 1 inhibitor | 0.04 0.012 DBMET00919 | DBMET00919 | |
| 0.013 | 0.714 | 0.141 | DOPA decarboxylase inhibitor | 0.141 0.027 DBMET00918 0.122 0.043 DBMET00919 0.113 0.053 DBMET00920 | DBMET00918 | |
| 0.006 | 0.708 | 0.062 | Thymidine kinase inhibitor | 0.053 0.017 DBMET00918 0.062 0.013 DBMET00919 | DBMET00919 | |
| 0.005 | 0.709 | 0.038 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.038 0.005 DBMET00919 | DBMET00919 | |
| 0.004 | 0.71 | 0.046 | Beta adrenoreceptor agonist | 0.046 0.028 DBMET00919 | DBMET00919 | |
| 0.001 | 0.711 | 0.04 | Uridine phosphorylase inhibitor | 0.032 0.016 DBMET00919 0.04 0.012 DBMET00920 | DBMET00920 | |
| 0.003 | 0.714 | 0.028 | Carnitine palmitoyltransferase 1A inhibitor | 0.028 0.021 DBMET00918 | DBMET00918 | |
| 0.008 | 0.719 | 0.071 | Beta 3 adrenoreceptor antagonist | 0.071 0.032 DBMET00919 | DBMET00919 | |
| 0 | 0.712 | 0.005 | Reverse transcriptase (HBV) inhibitor | 0.005 0.003 DBMET00919 | DBMET00919 | |
| 0.004 | 0.718 | 0.126 | Phenylalanine 4-hydroxylase inhibitor | 0.126 0.017 DBMET00918 0.111 0.021 DBMET00919 0.119 0.018 DBMET00920 | DBMET00918 | |
| 0.068 | 0.782 | 0.574 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.524 0.024 DBMET00918 0.574 0.011 DBMET00919 0.417 0.086 DBMET00920 | DBMET00919 | |
| 0.008 | 0.722 | 0.12 | Acetylcholine antagonist | 0.12 0.07 DBMET00919 | DBMET00919 | |
| 0.003 | 0.717 | 0.019 | CXC chemokine 5 receptor antagonist | 0.019 0.01 DBMET00918 | DBMET00918 | |
| 0.003 | 0.717 | 0.059 | Sphingosine 1-phosphate receptor agonist | 0.059 0.018 DBMET00918 0.047 0.028 DBMET00919 | DBMET00918 | |
| 0.067 | 0.783 | 0.278 | 5 Hydroxytryptamine 3E antagonist | 0.217 0.04 DBMET00918 0.278 0.008 DBMET00919 0.199 0.063 DBMET00920 | DBMET00919 | |
| 0.005 | 0.724 | 0.226 | Cytidine deaminase inhibitor | 0.176 0.059 DBMET00918 0.226 0.036 DBMET00919 | DBMET00919 | |
| 0.004 | 0.724 | 0.072 | Diacylglycerol O-acyltransferase inhibitor | 0.072 0.018 DBMET00918 | DBMET00918 | |
| 0.034 | 0.756 | 0.441 | GABA C receptor rho-3 antagonist | 0.441 0.045 DBMET00918 0.423 0.052 DBMET00919 0.362 0.079 DBMET00920 | DBMET00918 | |
| 0.003 | 0.728 | 0.05 | Matrix metalloproteinase (membrane-type) inhibitor | 0.05 0.046 DBMET00918 | DBMET00918 | |
| 0.006 | 0.734 | 0.08 | Glucosylceramidase inhibitor | 0.08 0.015 DBMET00919 | DBMET00919 | |
| 0.002 | 0.731 | 0.018 | Integrin beta3 antagonist | 0.018 0.015 DBMET00918 | DBMET00918 | |
| 0.008 | 0.738 | 0.315 | Ferrochelatase inhibitor | 0.315 0.006 DBMET00918 0.177 0.028 DBMET00919 0.103 0.068 DBMET00920 | DBMET00918 | |
| 0.001 | 0.732 | 0.028 | Lysine carboxypeptidase inhibitor | 0.028 0.018 DBMET00918 | DBMET00918 | |
| 0.014 | 0.745 | 0.145 | HIV-1 integrase (Overall Integration) inhibitor | 0.13 0.034 DBMET00918 0.145 0.027 DBMET00919 | DBMET00919 | |
| 0.002 | 0.733 | 0.022 | Glutaminyl-peptide cyclotransferase inhibitor | 0.022 0.014 DBMET00919 | DBMET00919 | |
| 0.009 | 0.741 | 0.083 | Phosphodiesterase 1A inhibitor | 0.083 0.015 DBMET00919 | DBMET00919 | |
| 0.002 | 0.734 | 0.049 | Carnitine palmitoyltransferase 1 inhibitor | 0.049 0.008 DBMET00918 0.035 0.022 DBMET00919 | DBMET00918 | |
| 0.003 | 0.737 | 0.113 | Argininosuccinate synthase inhibitor | 0.113 0.016 DBMET00918 0.054 0.043 DBMET00919 | DBMET00918 | |
| 0.001 | 0.737 | 0.016 | Cyclin D2 inhibitor | 0.016 0.005 DBMET00919 | DBMET00919 | |
| 0.017 | 0.752 | 0.155 | Neurotensin receptor agonist | 0.155 0.089 DBMET00918 | DBMET00918 | |
| 0.002 | 0.74 | 0.05 | Carnitine palmitoyltransferase inhibitor | 0.05 0.008 DBMET00918 0.034 0.023 DBMET00919 | DBMET00918 | |
| 0.04 | 0.78 | 0.104 | Sphingosine 1-phosphate receptor 2 agonist | 0.104 0.09 DBMET00919 | DBMET00919 | |
| 0.019 | 0.759 | 0.189 | 3C-like protease (Human coronavirus) inhibitor | 0.178 0.067 DBMET00918 0.189 0.059 DBMET00919 | DBMET00919 | |
| 0.013 | 0.753 | 0.15 | Insulin secretagoues | 0.15 0.074 DBMET00916 | DBMET00916 | |
| 0.008 | 0.748 | 0.083 | Uric acid excretion stimulant | 0.083 0.078 DBMET00918 | DBMET00918 | |
| 0.001 | 0.742 | 0.045 | Free fatty acid receptor 1 antagonist | 0.045 0.012 DBMET00918 | DBMET00918 | |
| 0.052 | 0.793 | 0.224 | Nitric-oxide synthase stimulant | 0.204 0.083 DBMET00918 0.204 0.082 DBMET00919 0.224 0.055 DBMET00920 | DBMET00920 | |
| 0.004 | 0.748 | 0.094 | Insulin growth factor antagonist | 0.094 0.05 DBMET00919 | DBMET00919 | |
| 0.005 | 0.749 | 0.101 | Antihistaminic | 0.101 0.054 DBMET00919 | DBMET00919 | |
| 0.004 | 0.749 | 0.089 | Insulin like growth factor 1 antagonist | 0.089 0.051 DBMET00919 | DBMET00919 | |
| 0.003 | 0.749 | 0.055 | Acetylcholine M2 receptor antagonist | 0.055 0.049 DBMET00919 | DBMET00919 | |
| 0.002 | 0.75 | 0.057 | NMDA 2C receptor antagonist | 0.057 0.049 DBMET00918 | DBMET00918 | |
| 0.01 | 0.759 | 0.075 | Purinergic P2X1 antagonist | 0.075 0.028 DBMET00918 0.057 0.048 DBMET00919 | DBMET00918 | |
| 0.001 | 0.751 | 0.01 | Integrin alphaVbeta5 antagonist | 0.01 0.007 DBMET00918 | DBMET00918 | |
| 0.004 | 0.755 | 0.094 | Integrin antagonist | 0.094 0.017 DBMET00918 | DBMET00918 | |
| 0.003 | 0.754 | 0.079 | Acetylcholine muscarinic agonist | 0.079 0.023 DBMET00919 0.062 0.032 DBMET00920 | DBMET00919 | |
| 0.012 | 0.763 | 0.084 | Vanilloid 4 agonist | 0.084 0.035 DBMET00918 0.082 0.038 DBMET00919 0.072 0.058 DBMET00920 | DBMET00918 | |
| 0.003 | 0.754 | 0.031 | Kainate receptor 3 antagonist | 0.031 0.005 DBMET00918 | DBMET00918 | |
| 0.003 | 0.756 | 0.06 | Sphingosine kinase 1 inhibitor | 0.06 0.009 DBMET00919 | DBMET00919 | |
| 0.004 | 0.758 | 0.039 | AMPA receptor agonist | 0.039 0.019 DBMET00919 | DBMET00919 | |
| 0.01 | 0.764 | 0.103 | MDM2 inhibitor | 0.101 0.006 DBMET00918 0.103 0.006 DBMET00919 | DBMET00919 | |
| 0.018 | 0.773 | 0.114 | Glutamate (mGluR7) agonist | 0.114 0.038 DBMET00918 0.11 0.043 DBMET00919 | DBMET00918 | |
| 0.01 | 0.765 | 0.136 | Cathepsin H inhibitor | 0.136 0.057 DBMET00918 0.119 0.076 DBMET00919 | DBMET00918 | |
| 0.004 | 0.761 | 0.036 | Purinergic P2X3 antagonist | 0.036 0.021 DBMET00919 | DBMET00919 | |
| 0.003 | 0.76 | 0.112 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.099 0.014 DBMET00918 0.112 0.012 DBMET00919 0.088 0.017 DBMET00920 | DBMET00919 | |
| 0.015 | 0.773 | 0.204 | EphB2 antagonist | 0.204 0.085 DBMET00919 | DBMET00919 | |
| 0.018 | 0.776 | 0.158 | Histone acetyltransferase inhibitor | 0.158 0.129 DBMET00919 | DBMET00919 | |
| 0.004 | 0.765 | 0.107 | Adrenaline agonist | 0.107 0.032 DBMET00919 | DBMET00919 | |
| 0.003 | 0.766 | 0.058 | Dopamine D3 antagonist | 0.058 0.047 DBMET00919 | DBMET00919 | |
| 0.021 | 0.785 | 0.06 | Calcium channel P-type blocker | 0.06 0.056 DBMET00919 | DBMET00919 | |
| 0.004 | 0.768 | 0.085 | mTOR inhibitor | 0.085 0.015 DBMET00919 | DBMET00919 | |
| 0.002 | 0.766 | 0.05 | Dopamine D4 antagonist | 0.05 0.049 DBMET00919 | DBMET00919 | |
| 0.002 | 0.767 | 0.077 | Cannabinoid CB2 receptor agonist | 0.077 0.026 DBMET00919 | DBMET00919 | |
| 0.005 | 0.77 | 0.124 | Glutamate (mGluR group III) antagonist | 0.124 0.004 DBMET00918 | DBMET00918 | |
| 0.004 | 0.778 | 0.057 | Epithelial sodium channel blocker | 0.057 0.033 DBMET00919 | DBMET00919 | |
| 0.002 | 0.777 | 0.079 | NMDA receptor glycine site agonist | 0.079 0.029 DBMET00918 0.063 0.043 DBMET00919 | DBMET00918 | |
| 0.004 | 0.781 | 0.135 | Alcohol dehydrogenase inhibitor | 0.135 0.026 DBMET00918 0.089 0.065 DBMET00919 | DBMET00918 | |
| 0.001 | 0.778 | 0.018 | Integrin alphaVbeta6 antagonist | 0.018 0.006 DBMET00918 | DBMET00918 | |
| 0.003 | 0.783 | 0.106 | Fibroblast growth factor 2 antagonist | 0.106 0.022 DBMET00919 | DBMET00919 | |
| 0.001 | 0.785 | 0.035 | Urate transporter 1 inhibitor | 0.035 0.032 DBMET00918 | DBMET00918 | |
| 0.003 | 0.787 | 0.033 | Diacylglycerol O-acyltransferase 1 inhibitor | 0.033 0.017 DBMET00918 | DBMET00918 | |
| 0.02 | 0.804 | 0.177 | MAP kinase 3 inhibitor | 0.177 0.037 DBMET00919 | DBMET00919 | |
| 0.003 | 0.788 | 0.064 | Alpha adrenoreceptor agonist | 0.064 0.051 DBMET00919 | DBMET00919 | |
| 0.005 | 0.791 | 0.076 | Carbonic anhydrase stimulant | 0.076 0.028 DBMET00918 | DBMET00918 | |
| 0.002 | 0.791 | 0.026 | Acid ceramidase inhibitor | 0.026 0.015 DBMET00919 | DBMET00919 | |
| 0.003 | 0.793 | 0.062 | Sphingosine 1-phosphate receptor 4 agonist | 0.062 0.053 DBMET00919 | DBMET00919 | |
| 0.002 | 0.793 | 0.055 | Acetylcholine M3 receptor antagonist | 0.055 0.048 DBMET00919 | DBMET00919 | |
| 0.002 | 0.794 | 0.027 | Peptide deformylase inhibitor | 0.027 0.026 DBMET00919 | DBMET00919 | |
| 0.005 | 0.798 | 0.139 | Activin receptor-like kinase 2 inhibitor | 0.139 0.076 DBMET00919 | DBMET00919 | |
| 0.003 | 0.797 | 0.089 | 5 Hydroxytryptamine 2 antagonist | 0.089 0.081 DBMET00919 | DBMET00919 | |
| 0.004 | 0.798 | 0.071 | NMDA receptor agonist | 0.071 0.035 DBMET00918 | DBMET00918 | |
| 0.004 | 0.8 | 0.199 | MAP kinase kinase 1 inhibitor | 0.084 0.08 DBMET00918 0.19 0.005 DBMET00919 0.199 0.005 DBMET00920 | DBMET00920 | |
| 0.001 | 0.8 | 0.022 | Glutamate (mGluR1a) agonist | 0.022 0.016 DBMET00918 | DBMET00918 | |
| 0.002 | 0.802 | 0.043 | Nerve growth factor antagonist | 0.043 0.029 DBMET00918 | DBMET00918 | |
| 0.006 | 0.808 | 0.128 | Neuropeptide Y1 antagonist | 0.128 0.105 DBMET00918 | DBMET00918 | |
| 0.004 | 0.808 | 0.063 | Heparanase inhibitor | 0.063 0.018 DBMET00916 | DBMET00916 | |
| 0.005 | 0.812 | 0.14 | Falcipain 3 inhibitor | 0.14 0.041 DBMET00918 0.129 0.048 DBMET00919 | DBMET00918 | |
| 0.002 | 0.81 | 0.101 | Cannabinoid CB1 receptor agonist | 0.101 0.019 DBMET00919 | DBMET00919 | |
| 0.003 | 0.812 | 0.061 | Collagenase 3 inhibitor | 0.061 0.04 DBMET00918 | DBMET00918 | |
| 0.005 | 0.815 | 0.196 | Focal adhesion kinase 2 inhibitor | 0.145 0.138 DBMET00918 0.196 0.072 DBMET00919 | DBMET00919 | |
| 0.005 | 0.815 | 0.097 | Bromodomain-containing protein 2 inhibitor | 0.097 0.044 DBMET00919 | DBMET00919 | |
| 0.017 | 0.828 | 0.145 | CF transmembrane conductance regulator agonist | 0.141 0.093 DBMET00918 0.145 0.085 DBMET00919 | DBMET00919 | |
| 0.004 | 0.818 | 0.174 | Sphingosine 1-phosphate receptor 2 antagonist | 0.174 0.019 DBMET00918 0.144 0.049 DBMET00919 0.122 0.093 DBMET00920 | DBMET00918 | |
| 0.006 | 0.821 | 0.042 | Heme oxygenase inhibitor | 0.042 0.035 DBMET00918 0.042 0.031 DBMET00919 | DBMET00919 | |
| 0.006 | 0.825 | 0.151 | Glutamate (mGluR4) antagonist | 0.151 0.004 DBMET00918 0.048 0.023 DBMET00919 0.042 0.033 DBMET00920 | DBMET00918 | |
| 0.009 | 0.828 | 0.114 | Electrolyte absorption antagonist | 0.114 0.041 DBMET00918 0.087 0.081 DBMET00919 | DBMET00918 | |
| 0.002 | 0.822 | 0.044 | Purinergic P2Y antagonist | 0.044 0.032 DBMET00919 | DBMET00919 | |
| 0.003 | 0.827 | 0.332 | Raf kinase C inhibitor | 0.332 0.005 DBMET00920 | DBMET00920 | |
| 0.005 | 0.83 | 0.084 | Histamine H2 receptor antagonist | 0.084 0.056 DBMET00919 | DBMET00919 | |
| 0.001 | 0.828 | 0.039 | Glutamate (mGluR group II) antagonist | 0.039 0.026 DBMET00918 | DBMET00918 | |
| 0.001 | 0.83 | 0.058 | Acetylcholine M1 receptor agonist | 0.058 0.022 DBMET00919 0.043 0.03 DBMET00920 | DBMET00919 | |
| 0.003 | 0.833 | 0.089 | Histamine antagonist | 0.089 0.055 DBMET00919 | DBMET00919 | |
| 0.003 | 0.835 | 0.072 | Nicotinic alpha4beta2 receptor antagonist | 0.072 0.059 DBMET00919 | DBMET00919 | |
| 0.004 | 0.838 | 0.033 | Vanilloid 4 antagonist | 0.033 0.022 DBMET00919 | DBMET00919 | |
| 0.004 | 0.845 | 0.109 | 5 Hydroxytryptamine 2B antagonist | 0.109 0.072 DBMET00919 | DBMET00919 | |
| 0.003 | 0.846 | 0.047 | Tryptophan 5 hydroxylase inhibitor | 0.047 0.007 DBMET00918 0.034 0.03 DBMET00919 | DBMET00918 | |
| 0.001 | 0.845 | 0.07 | Kainate receptor 2 antagonist | 0.07 0.009 DBMET00918 | DBMET00918 | |
| 0.005 | 0.851 | 0.134 | 5 Hydroxytryptamine 3A agonist | 0.112 0.063 DBMET00918 0.134 0.045 DBMET00919 | DBMET00919 | |
| 0.002 | 0.851 | 0.094 | Cannabinoid receptor agonist | 0.094 0.028 DBMET00919 | DBMET00919 | |
| 0.002 | 0.852 | 0.042 | Glutamate (mGluR1a) antagonist | 0.042 0.027 DBMET00919 | DBMET00919 | |
| 0.005 | 0.855 | 0.09 | Histamine N-methyltransferase inhibitor | 0.079 0.068 DBMET00918 0.09 0.056 DBMET00919 | DBMET00919 | |
| 0.004 | 0.857 | 0.242 | MAP kinase kinase inhibitor | 0.211 0.025 DBMET00919 0.242 0.017 DBMET00920 | DBMET00920 | |
| 0.006 | 0.859 | 0.104 | 5 Hydroxytryptamine 3 agonist | 0.104 0.014 DBMET00919 | DBMET00919 | |
| 0.002 | 0.856 | 0.064 | Syk tyrosine kinase inhibitor | 0.064 0.055 DBMET00919 | DBMET00919 | |
| 0.004 | 0.86 | 0.109 | Insulin receptor antagonist | 0.109 0.051 DBMET00919 | DBMET00919 | |
| 0.002 | 0.859 | 0.082 | Cyclin-dependent kinase 6 inhibitor | 0.058 0.043 DBMET00918 0.082 0.02 DBMET00919 | DBMET00919 | |
| 0.005 | 0.866 | 0.075 | Cyclin D1 inhibitor | 0.075 0.023 DBMET00919 | DBMET00919 | |
| 0.003 | 0.864 | 0.08 | Sphingosine kinase 2 inhibitor | 0.08 0.015 DBMET00919 0.066 0.025 DBMET00920 | DBMET00919 | |
| 0.002 | 0.863 | 0.028 | Thymidine phosphorylase inhibitor | 0.027 0.016 DBMET00918 0.028 0.015 DBMET00919 | DBMET00919 | |
| 0.002 | 0.867 | 0.109 | MAP kinase kinase kinase inhibitor | 0.109 0.059 DBMET00919 | DBMET00919 | |
| 0.001 | 0.867 | 0.026 | Purinergic P2Y15 antagonist | 0.026 0.025 DBMET00919 | DBMET00919 | |
| 0.001 | 0.869 | 0.033 | MAP3K8 inhibitor | 0.03 0.018 DBMET00918 0.033 0.013 DBMET00919 | DBMET00919 | |
| 0.003 | 0.873 | 0.099 | Acetylcholine agonist | 0.099 0.047 DBMET00919 | DBMET00919 | |
| 0.001 | 0.873 | 0.072 | Fibroblast growth factor 3 antagonist | 0.072 0.062 DBMET00919 | DBMET00919 | |
| 0.004 | 0.876 | 0.234 | MAP kinase kinase 2 inhibitor | 0.234 0.062 DBMET00919 | DBMET00919 | |
| 0.008 | 0.88 | 0.158 | Nav1.2 sodium channel blocker | 0.158 0.052 DBMET00919 | DBMET00919 | |
| 0.004 | 0.877 | 0.039 | CC chemokine 10 receptor antagonist | 0.039 0.003 DBMET00920 | DBMET00920 | |
| 0.01 | 0.884 | 0.11 | Lanosterol 14 alpha demethylase inhibitor | 0.109 0.043 DBMET00918 0.11 0.042 DBMET00919 | DBMET00919 | |
| 0.001 | 0.875 | 0.067 | Glycine transporter inhibitor | 0.067 0.022 DBMET00918 | DBMET00918 | |
| 0.005 | 0.879 | 0.154 | Sphingosine 1-phosphate receptor 5 antagonist | 0.15 0.06 DBMET00918 0.154 0.055 DBMET00919 0.151 0.06 DBMET00920 | DBMET00919 | |
| 0.002 | 0.879 | 0.039 | MAP3K5 inhibitor | 0.039 0.027 DBMET00918 0.038 0.029 DBMET00919 | DBMET00918 | |
| 0.004 | 0.881 | 0.248 | I kappa B kinase epsilon inhibitor | 0.248 0.039 DBMET00919 | DBMET00919 | |
| 0.001 | 0.878 | 0.036 | Diamine oxidase inhibitor | 0.036 0.029 DBMET00919 | DBMET00919 | |
| 0.003 | 0.881 | 0.089 | Bcr-Abl kinase inhibitor | 0.089 0.053 DBMET00919 | DBMET00919 | |
| 0.002 | 0.885 | 0.035 | Integrin alpha2 antagonist | 0.035 0.028 DBMET00918 | DBMET00918 | |
| 0.001 | 0.884 | 0.068 | Kainate receptor antagonist | 0.068 0.013 DBMET00918 | DBMET00918 | |
| 0 | 0.886 | 0.03 | Kainate receptor 1 antagonist | 0.03 0.01 DBMET00918 | DBMET00918 | |
| 0.002 | 0.889 | 0.025 | Integrin alpha2beta1 antagonist | 0.025 0.02 DBMET00918 | DBMET00918 | |
| 0.002 | 0.892 | 0.074 | Acetylcholine nicotinic agonist | 0.074 0.065 DBMET00919 | DBMET00919 | |
| 0.001 | 0.893 | 0.041 | Phosphorylase inhibitor | 0.041 0.036 DBMET00918 | DBMET00918 | |
| 0.009 | 0.902 | 0.12 | Nav1.3 sodium channel blocker | 0.12 0.073 DBMET00919 | DBMET00919 | |
| 0.001 | 0.894 | 0.068 | 5 Hydroxytryptamine 3A antagonist | 0.068 0.044 DBMET00919 | DBMET00919 | |
| 0.001 | 0.894 | 0.034 | Glutamate (mGluR3) antagonist | 0.034 0.029 DBMET00918 | DBMET00918 | |
| 0.003 | 0.897 | 0.284 | Raf kinase inhibitor | 0.284 0.007 DBMET00920 | DBMET00920 | |
| 0.003 | 0.897 | 0.052 | Sphingosine 1-phosphate receptor 1 antagonist | 0.052 0.047 DBMET00918 | DBMET00918 | |
| 0.001 | 0.902 | 0.056 | Vascular adhesion protein 1 inhibitor | 0.036 0.032 DBMET00918 0.056 0.011 DBMET00919 | DBMET00919 | |
| 0.003 | 0.91 | 0.257 | Protein kinase (Mos, Mil/Raf, MEKK, RIPK, TESK, LIMK, IRAK, ILK, Activin/TGF-beta) inhibitor | 0.257 0.012 DBMET00920 | DBMET00920 | |
| 0.004 | 0.916 | 0.096 | Nav1.5 sodium channel blocker | 0.096 0.093 DBMET00919 | DBMET00919 | |
| 0.001 | 0.916 | 0.056 | Toll-Like receptor 8 antagonist | 0.056 0.035 DBMET00919 | DBMET00919 | |
| 0.003 | 0.918 | 0.083 | Polo-like kinase-1 inhibitor | 0.083 0.076 DBMET00919 | DBMET00919 | |
| 0.002 | 0.919 | 0.037 | AMPA 4 receptor antagonist | 0.037 0.032 DBMET00918 | DBMET00918 | |
| 0.004 | 0.924 | 0.827 | Ca2+/calmodulin-dependent protein kinase inhibitor | 0.827 0.003 DBMET00920 | DBMET00920 | |
| 0.004 | 0.929 | 0.142 | Nav1.6 sodium channel blocker | 0.142 0.064 DBMET00919 | DBMET00919 | |
| 0.003 | 0.929 | 0.16 | Cyclin-dependent kinase 8 inhibitor | 0.16 0.07 DBMET00919 | DBMET00919 | |
| 0.004 | 0.934 | 0.068 | Purinergic P2 antagonist | 0.068 0.041 DBMET00920 | DBMET00920 | |
| 0.001 | 0.932 | 0.095 | Interleukin-1 receptor-associated protein kinase 4 inhibitor | 0.095 0.051 DBMET00919 | DBMET00919 | |
| 0.002 | 0.935 | 0.068 | Glutamate receptor agonist | 0.068 0.065 DBMET00918 | DBMET00918 | |
| 0.001 | 0.939 | 0.044 | AMPA receptor antagonist | 0.044 0.037 DBMET00918 | DBMET00918 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |